WO1999049937A1 - Method and apparatus for the selective targeting of lipid-rich tissues - Google Patents

Method and apparatus for the selective targeting of lipid-rich tissues Download PDF

Info

Publication number
WO1999049937A1
WO1999049937A1 PCT/US1999/006475 US9906475W WO9949937A1 WO 1999049937 A1 WO1999049937 A1 WO 1999049937A1 US 9906475 W US9906475 W US 9906475W WO 9949937 A1 WO9949937 A1 WO 9949937A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipid
tissue
fat
skin
radiation
Prior art date
Application number
PCT/US1999/006475
Other languages
French (fr)
Inventor
R. Rox Anderson
Gregory B. Altshuler
Dieter Manstein
Original Assignee
The General Hospital Corporation
Palomar Medical Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corporation, Palomar Medical Technologies, Inc. filed Critical The General Hospital Corporation
Priority to ES99915023T priority Critical patent/ES2403359T3/en
Priority to AU33639/99A priority patent/AU3363999A/en
Priority to EP99915023A priority patent/EP1066086B1/en
Priority to CA2326120A priority patent/CA2326120C/en
Publication of WO1999049937A1 publication Critical patent/WO1999049937A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30Surgical pincettes without pivotal connections
    • A61B2017/306Surgical pincettes without pivotal connections holding by means of suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • A61B2018/00458Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • A61B2018/00464Subcutaneous fat, e.g. liposuction, lipolysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • A61B2018/00476Hair follicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/208Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser with multiple treatment beams not sharing a common path, e.g. non-axial or parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • A61N5/0617Hair treatment

Definitions

  • This invention relates to methods and apparatus for the selective heating of lipid-rich tissue including sebaceous glands, subcutaneous fat, lipid in membranes of cells, and fat surrounding organs, vessels, hair bulbs, and other anatomical elements, and/or to the selective destruction or removal of such tissue and/or structures adjacent thereto; and more particularly to methods and apparatus for using optical radiation in selected wavebands, which radiation may be obtained from a laser or other suitable light source, to effect such heating, removal and/or destruction.
  • Adipose or lipid-rich tissue which is also sometimes referred to as “fat” or “fatty tissue”
  • fat is a common cosmetic and surgical problem
  • body fat may also pose certain other health risks.
  • Many factors, including heredity, glandular function, nutrition and lifestyle affect both the extent and location of body fat.
  • liposuction a procedure in which fat is removed by a suction cannula under local anesthesia, or other forms of fat excision have been used. Fat also occurs in pads on the face and neck and small area local liposuction has sometimes been performed in these areas.
  • liposuction is an invasive surgical procedure and presents all of the disadvantages and risks to the patient involved in such a procedure, including scars at the sites of entry into skin.
  • Another problem with liposuction is that it is not selective in only removing unwanted fat, but also rips out tissue in the path of the liposuction hose, including the collagen supporting structure holding the patient's skin in place. This can result in cosmetically unattractive sagging skin in the treated area, in addition to significant pain to the patient both during and after the procedure, risk of infection and other potential problems.
  • the trauma caused by extreme liposuction has in some cases even resulted in the death of the patient.
  • liposuction can be used for the removal of deep fat, it is significantly less - 2 - effective for removing fat at a superficial level of subcutaneous fat just below the dermis. Such removal is desirable in some cases because it is less traumatic to the patient.
  • liposuction cannula without scratching the dermis, damage to the dermis not healing readily, and attempts to perform surface liposuction also result in an uneven removal of fat which leaves an esthetically unattractive patterning on the patient's skin. Therefore, while liposuction is still used extensively for the removal of excess fat, it is not a desirable procedure.
  • Fat is also a problem in various surgical procedures where it may be difficult to locate vessels, organs or other anatomical elements on which surgery is to be performed when these elements are covered in fat, and it may be difficult to close surgical openings in such elements. Performing surgery on vessels, organs or other elements covered by fat is therefore risky and current procedures for removing such fat to facilitate surgical procedures have significant limitations. Of particular concern is mesenteric fat which is a common hindrance in laparoscopic surgery. With the current trend of making surgical procedures less invasive by inserting tools through a small surgical opening, the removal of fat in the region where a surgical procedure is being performed, utilizing a tool consistent with such surgical procedures, so as to facilitate remote viewing of the anatomical element being treated/operated on is therefore becoming increasingly important.
  • acne a major problem for teenagers and others is acne which originates at least in part from obstruction of outflow from a sebaceous gland.
  • Certain drug treatments for acne operate through a mechanism of decreasing sebaceous gland output. Destruction, removal, or unblocking of the sebaceous gland, which gland contains lipid-rich tissue, in a non-invasive manner are therefore desirable alternatives for treatment or prevention of acne.
  • Another related problem is the removal of unwanted hair, and in particular the long-term or permanent removal of such hair by the damage or destruction of the hair follicle.
  • Many techniques have been employed over the years for this treatment, including electrolysis, waxing and treatments with various forms of radiation, including light.
  • electrolysis is slow and both electrolysis and waxing are painful to the patient and seldom permanent.
  • Various radiation treatments, particularly those involving light work more effectively for patients having darker hair than for patients with light hair and various proposals have been made over the years to add a chromophore in some way to the follicle to facilitate such treatments.
  • the use of such artificial chromphores has not heretofore been particularly successful. - 3 -
  • lipid-rich tissue such as subcutaneous fat
  • the lasers proposed for such procedures have operated at a wavelength where lipid-rich tissue has an absorption coefficient which is generally significantly less then than that for water.
  • lipid-rich tissue is radiation heated as a result of absorption in the tissue of radiation energy. Therefore, for wavelengths at which lipid-rich tissue does not absorb the radiation strongly, large amounts of energy must be applied to the tissue in order to obtain the requisite heating.
  • the need for high energy poses a danger of damage to surrounding tissue or the tissue through which the radiation passes, particularly since most such tissue is primarily composed of water which absorbs the radiant energy much more at these wavelengths.
  • subcutaneous fat which generally starts at a depth of at least 1 to 4 mm into a patient's skin, and may be deeper for some individuals or some body areas. Therefore, in order for the radiation to target to the subcutaneous fat to cause selective heating or destruction thereof, it must pass through several millimeters of tissue formed primarily of water. Since water preferentially absorbs at these wavelengths, most of the incident radiation is absorbed in the skin prior to reaching the subcutaneous fat and, since skin is a scattering medium, incident light is also scattered and reflected from the patient's skin, resulting in a very small fraction of the incident light reaching the subcutaneous fat.
  • this invention provides a method and apparatus for selectively targeting lipid-rich tissue to effect a desired treatment, the method/apparatus involving irradiating the lipid-rich tissue at an infrared wavelength at which the ratio of absorption of the radiation by lipid-rich tissue to absorption by water is 0.5 or greater, and preferably greater than one.
  • the irradiation is preferably at a wavelength between 880-935 nm, 1150 to 1230 nm, 1690 to 1780 nm, or 2250 to 2450 nm with a fluence and for a duration sufficient to treat such lipid-rich tissue.
  • the irradiation wavelength is between approximately, 900 to 930 nm, 1190 to 1220 nm, 1700 to 1730 nm, or 2280 to 2360 nm, with approximately 920 nm, 1210 nm, 1715 nm, and 2300 nm being most preferred wavelengths.
  • the treatment fluence may for example be approximately 0.5 J/cm 2 to 500 J/cm 2 , with the duration of treatment pulses being - 5 - approximately 10 ⁇ s to several seconds, or even minutes for photothermal effect, and less than 1 ⁇ s (i.e., generally 1 ⁇ s to 1 ns) for photomechanical effects.
  • irradiating the tissue/gland is performed by applying the energy at an indicated wavelength, which wavelength is preferably in one of the higher bands, to the skin surface overlying such one or more sebaceous glands.
  • energy may be applied to the skin surface overlying the subcutaneous fat to be treated.
  • the radiation is preferably applied through an applicator which applies pressure to the skin above the lipid-rich tissue being treated.
  • This pressure reduces the distance from the radiation- applying applicator to the lipid-rich tissue being targeted, removes blood from the area above the fat tissue being targeted and compresses such overlying tissue to reduce scattering and enhance optical focusing of radiation on the treatment area. It is also desirable that the skin above the area being treated be cooled to a selected depth, which depth is above that of the lipid-rich/fat tissue being targeted. Thus, cooling could be deeper for the treatment of subcutaneous fat, where the cooling could be most of the way through the dermis, while the cooling would be to a much shallower depth, perhaps only to the dermis/epidermis (DE) junction, where the sebaceous gland is being treated.
  • DE dermis/epidermis
  • a fold of skin may be drawn into a recess in a radiation delivery head in a suitable manner and radiation applied to the recess from at least two directions.
  • a convergent incident beam is advantageous to compensate for losses due to optical scattering and absorption in the dermis.
  • the sebaceous gland may be heated to destroy the gland as part of an acne treatment
  • the sebaceous gland may also be heated to cause destruction of adjacent areas of a hair follicle, for example the stem cells of the hair follicle as a treatment to achieve hair removal and impede regrowth.
  • Radiation in the indicated wavelengths may also be applied selectively to cells having lipid-rich membranes to porate the membranes to for example permit selective drug delivery to the cells or for other purposes for lipid-rich cells or tissue may be otherwise targeted and heated for affecting some other therapeutic function. Since the radiation fluence, pulse duration, wavelength and other factors may be carefully controlled, and the area to which the radiation is directed may also be controlled, selective lipid-rich cells may be non-invasively targeted to achieve the above and other therapeutic affects.
  • duration of radiation pulse and the temperature to which the fat or lipid tissue is heated are critical to the desired results.
  • fat is altered by a biochemical reaction or lipolysis, while for higher temperatures and sufficient pulse duration, fat cells are killed, permitting the cells and liquid lipid therein to be absorbed.
  • cell membranes are destroyed, permitting lipid pools to be formed. These pools may also be absorbed but, since free fatty acid in lipid can be toxic in sufficient quantity, if substantial quantities of fat cell membranes have been destroyed, permitting a large lipid pool to be formed, it is preferable to remove the lipid, for example with a cannula or needle.
  • the heated collagen of supporting structure may react to provide a more pleasing skin appearance after treatment and avoid sagging folds of skin or skin depressions where the lipid tissue has been destroyed. While all of the fat in a subcutaneous layer may be treated, it is difficult to get sufficient energy deep into the fat, so treatment is generally restricted to a surface layer of the fat. Repetitive treatments may be performed to remove successive layers of the subcutaneous fat. While non-invasive procedures are preferable, subcutaneous fat may also be treated by passing a probe through the skin to the subcutaneous fat to be treated.
  • the probe which may for example be a needle, may be passed into the subcutaneous fat at an angle to the skin surface and the probe may be moved both in an out of the skin and rotated about its skin entry point to irradiate and treat subcutaneous fat over a selected area.
  • This needle or probe may also contain a cannula for removing liquid lipid pooled as indicated above from the radiation treatment
  • the irradiation may be performed by use - 7 - of a tool which is in at least near contact, and preferably in contact, with the fat to be treated, the element treating the fat to expose the anatomical element on which the procedure is to be performed. Because radiation for this embodiment does not need to pass through water rich tissue to reach the fat, wavelengths in the higher bands would normally be used for this procedure.
  • the preferred light source at the desired wavelengths is a diode laser or lasers with flashlamp or diode pumping which will be described in greater detail later.
  • Fig. 1 is a diagrammatic sectional view of human skin illustrating both a hair follicle with a sebaceous gland and subcutaneous fat.
  • Fig. 2A is a sectional view illustrating an area of subcutaneous fat under treatment in accordance with the teachings of a first embodiment of this invention.
  • Fig. 2B is a sectional view illustrating an area of skin, either subcutaneous fat, sebaceous gland or other targeted lipid-rich tissue, under treatment in accordance with an alternative embodiment of the invention.
  • Fig. 3 is a sectional view illustrating a section of skin with subcutaneous fat under treatment employing another alternative embodiment of the invention.
  • Fig. 4 is a sectional view illustrating a tool being utilized to clear fat from a vessel on which a surgical procedure is to be performed in accordance with the teachings of this invention.
  • Fig. 5 is a graph illustrating the coefficient of absorption of water and of human fatty tissue as a function of wavelength.
  • Fig. 6 is a graph illustrating the ratio of human fatty tissue coefficient of absorption to water coefficient of absorption as a function of wavelength. - 8 -
  • Fig. 1 is a simplified sectional view through a piece of human skin 10 illustrating the major skin layers.
  • the outermost layer is the epidermis 12 which overlies the dermis 14.
  • Under the dermis is a layer of subcutaneous fat 16.
  • the epidermis is typically relatively thin, on the order of 0.1 mm, although this thickness varies for different parts of the body, with the lower portions of the epidermis near the DE junction 18 containing quantities of melanin which vary with the pigmentation of the individuals skin.
  • the thickness of dermis layer 14 varies from approximately 1 to 5 mm depending on the part of the body and on the individual, and may be thicker in some instances.
  • the lower third of the dermis typically contains numerous lobules of fat.
  • Fig. 1 also illustrates a single hair follicle 20 with an adjacent sebaceous gland 22.
  • Hair follicle 20 has a bulb or papilla 23 and stem cells in a bulge region 25, both of which are involved in the growth and regrowth of hair from the follicle.
  • Sebaceous glands 22 are formed primarily of fat/lipid-rich tissue. The cells lining the outer portion of sebaceous glands are called sebocytes. These cells migrate inward, synthesizing a lipid-rich fluid called sebum as they differentiate and finally are shed. The sebum flows outward through a duct into the infundibulum ("pore") of the follicle.
  • the greasy, oily material which accumulates on the surface of skin is sebum, after flowing out of numerous follicles.
  • sebum When the outflow from a sebaceous gland becomes clogged, it may result in the formation of an acne pimple.
  • Sebaceous glands are typically found approximately 1 mm below the skin surface, although they may be at greater depths in some instances, and are in the dermal layer 14 as shown in Fig. 1.
  • the temperature rise in a given tissue as a result of absorbing a given amount of energy is a function of the density of the tissue and its heat capacity.
  • this temperature increase for absorbed energy is compared for water and fat or lipid-rich tissue, it is found that the temperature rise in the lipid-rich tissue for a given energy absorption is 1.8 to 2 times that for water. Therefore, lipid-rich tissue need absorb 0.5 to 0.6 as much energy to achieve the same temperature rise as for water.
  • lipid tissue preferentially absorbs at a wavelength for which the coefficient of absorption for fat is at least 0.5 that of water, although this ratio for preferred wavelengths is at least 1 and is 1.5 or higher for selected wavelengths.
  • both water and lipid absorb most strongly in the 2250 to 2450 nm range and absorb least strongly in the 900 to 930 nm range).
  • the ratio of lipid absorption to water absorption is also greater for the higher wavelengths, being over 1.5 for maximas at approximately 1715 nm and 2300 nm. Therefore, radiation within the above-indicated wavelength bands, and in particular radiation at or near various maxima in these bands such as 925 nm, 1210 to 1230 nm, 1715 nm, or 2300 nm would be particularly effective for treating lipid-rich tissue such as sebaceous glands or subcutaneous fat.
  • the depth which light/radiation reaches in a patient's skin is inversely proportional to light absorption above such depth. Since water is the primary constituent of skin tissue, water absorption is a controlling factor in the depth which radiation of a particular wavelength may reach in a patient's skin. Therefore, radiation in the 900 to 930 nm band and 1210 to 1230 nm band which are most weakly absorbed by water, while still being at least somewhat strongly absorbed by fat, are the currently preferred radiation bands for non-invasively treating subcutaneous fat, where the - 10 - radiation generally needs to reach at least 3 to 4 mm within the patient's skin.
  • radiation in the higher bands may be preferable for treating the sebaceous gland which is generally located only 1 mm into the patient's skin, since fat absorbs more strongly at these wavelengths and water absorption in the overlying skin is not as big a factor.
  • the longer wavelengths could also be used where a suitable light emitting probe is positioned adjacent the fat to be ablated, for example to clear fat from a vessel, organ or the like or where a needle is used to get to subcutaneous fat.
  • the first issue in implementing the teachings of this invention is to find a radiation source adapted for generating sufficient radiation at the required wavelengths.
  • commercially available lasers or other radiation sources are available for the 900-930 nm range and YAG lasers operate at approximately 1060 and 1300 nm
  • current commercially available lasers/radiation sources are not normally adapted for generating radiation at the other preferred wavelengths.
  • the following light sources with wavelengths around 920, 1200, 1715, or 2300 nm can be used for fatty tissue targeting:
  • Tungsten lamp or an arc lamp with an absorptive or reflective filter which filters the required spectral region. Optimum lamp temperature is in the region 1300-2000 K.
  • a filter the following can be used: crystals with color centers, liquid dyes or dyes in a solid matrix.
  • Diode lasers such as GaAs (920 nm), AlGaSbAs (1200, 1215 nm), InGaAsP/InP (1715 nm), InGaAs (2300 nm).
  • Lasers based on crystals with color centers and lamp or laser pumping These would include crystals NaF with F 2+ centers (1200 nm) or KC1 with F 2+ centers (1215 nm) or KClLi with F 2+ centers (2300 nm).
  • Lasers with non-linear wavelength conversion; optical parametric oscillators (OPO) or Raman converters can be used as such non-linear converters.
  • Solid state lasers can be used for pumping (Nd laser, Ho laser, Er laser, fiber laser etc.) of OPO or Raman converter. - 11 -
  • One of the most effective lasers can be a lamp pumped solid state laser with correct spectral lines.
  • crystals with ions Er 3+ can generate in the region 1200 nm ( 4 S 3/2 -> 4 I 11/12 ) and 1715 ( 4 S 3/2 ⁇ % /2 ).
  • one suitable laser is a potassium cadmium laser with the matrix KCd(WO 4 ) 2 which is doped with Er 3+ (erbium) ions.
  • the concentration of Er 3+ ions should be in the range of 1-10 percent, with the optimal concentration being approximately 2-5 percent.
  • the energy level transition 4 S 3/2 -4 4 I 9/2 should be used for laser generation.
  • Stark broadening and the wavelength for maximum laser output depend on the relative orientation of the crystal axis, laser radiation axis and polarization of laser radiation.
  • the spectral maximum of the laser output is at the desired 1715 nm wavelength.
  • Maximum efficiency is achieved when the axis of the laser beam lies in the plane determined by the crystalline axis [100] and [001] and is directed along the optical axis N m which forms an angle of 24 degrees with crystalline axis [100]. If the same crystal is used for laser generation along the crystalline axis [010], the wavelength of laser generation for the same transition is 1730 nm. Flashlamps, laser diodes, other lasers or other pump mechanisms can be used to pump the above crystal in order to achieve the desired wavelength output.
  • a diode laser generating an output at approximately 920 nm is used to pump a Yb doped glass or fiber with a laser wavelength of 1100 nm. This output is then frequency-doubled to obtain a wavelength of 550 nm which is the most efficient pumping wavelength and may be utilized for direct pumping of the 4 S 3/2 level.
  • Laser light from pumping diode laser (920 nm) can also be used for selectively heating fat. Control over the spectral distribution is achieved by changing mirrors or by a dispersive element inside the laser cavity.
  • Radiation at 1730 nm may be obtained if lasers based on YLF, YAG, YAL. YSGG or a fiber doped with Er 3+ ions are used.
  • Pumping methods and concentration of active ions is the same as for the KCd(WO 4 ) 2 :Er 3+ .
  • the concentration of EX ions should be in the range 1-50%, with an optimal ion concentration being in the range 2-5%.
  • Radiation at 1730 nm may be achieved using for example, an YLF:Er 3+ with concentration of Er 3+ 25% laser with flashlamp pumping.
  • the maximum output energy is 1 J
  • slope efficiency is 0.5 %
  • repetition rate is 4 Hz
  • the pulse width is 0.4 ms.
  • Certain diode lasers may also be utilized to generate radiation within the desired wavelength ranges.
  • a laser based on InGaAsP/InP can generate laser output in a range of wavelengths about 1700 nm with fine temperature tunability and stabilization.
  • Blackbody sources such as a tungsten lamp with suitable optical filters, can also be used to produce the desired radiation.
  • the spectral power and tissue selectivity of such light sources would be less than for laser sources.
  • the optimal temperature of the heat source should be about 1700 degrees K, with approximately 5 percent of the radiation of the lamp operating at this temperature being in the spectral region between 1700 nm and 1760 nm.
  • the desired wavelengths can also be achieved by a tunable laser like a dye laser, free electron laser, color center laser or Raman shifter, the efficiencies of these lasers is low and they are very expensive. They are therefore not as practical as other sources for this application.
  • an optical parametric oscillator with pumping from a solid state laser or a fiber laser could also generate energy at the desired wavelengths.
  • An OPO has maximum efficiency only for very short pulses, and would be most useful therefore when treatment is accomplished by photomechanical or photodissociation at 1 ns to 4 fs interactions.
  • Other light sources generating radiation within the indicated wavelength band might also be utilized in appropriate applications.
  • the time of exposure at a given site can be effectively used over a very wide range, but is preferably within either of two regions causing photothermal or photomechanical effects.
  • photothermal damage, or necrosis of lipid-rich tissues including fat and sebaceous glands exposure durations of 0.1 ms to several minutes and sometimes higher are desirable, depending on the size of the targeted structure (for example the sebaceous gland diameter or subcutaneous fate depth being treated).
  • photomechanically-mediated damage, or necrosis e.g. by violent castation, shock waves, or spallation, an exposure of less than 1 microsecond is desirable, and less than 10 ⁇ s is most preferred.
  • the longer exposure duration can be generated for example by a flashlamp-pumped laser, scanned or shuttered CW laser, or conventional sources described above.
  • the shorter exposure durations, less than 10 ⁇ s can be generated by Q-switching or mode-locking of laser cavities, or by an OPO or Raman-shifted Q-switched laser as described above.
  • Fig. 2 illustrates one way in which the teachings of this invention might be utilized to non-invasively treat either subcutaneous fat 16 (as shown in the figure), at least one sebaceous gland 22 or other targeted lipid-rich tissue.
  • an applicator 30, which could for example be of the type shown in U.S. Patents 5,595,568 or 5,735,844, is utilized.
  • Applicator 30 may have a lens 32 or other suitable contact element at the front end thereof, which element is adapted to be in pressure contact with the upper surface of epidermis 12, thereby deforming the skin in the contact area for example as shown in Fig. 2. Applying pressure to the skin in this way provides a number of advantages.
  • the pressure reduces the distance between the laser source and the sebaceous gland 22/ subcutaneous fat 16, thereby reducing the amount of tissue through which the light must pass prior to reaching the area under treatment. While radiation within the indicated bands is preferentially absorbed by the lipid- rich tissue, there is still absorption by the water/blood-containing tissue above the lipid-rich tissue being treated. Therefore, the greater the reduction in the quantity and thickness of this tissue, by for example tension, the less energy is lost in this tissue, resulting both in more energy being available for treatment at the desired location and in less heating, and therefore less potential thermal damage, to the lipid-poor tissue not under treatment.
  • the second advantage is that if the pressure is above the body's blood pressure (e.g., about 3 psi), the pressure will force blood out from under the applicator, further reducing absorption in the lipid-poor tissue through which the radiation passes. It has also been found that compressed tissue causes significantly less scattering of light energy passing therethrough, - 14 - or in other words is more transparent to such light energy, when under significant pressure than when not under such pressure. Not only does this phenomenon reduce radiant energy loss, and thus heating in the tissue above the tissue under treatment, but it also permits more effective focusing of light energy to facilitate heating and/or damage of only desired tissue.
  • Fig. 2 shows an exemplary such focused radiation beam 34 being directed to the upper portions of subcutaneous fat layer 16.
  • blood flowing through the dermis is one effective way of removing heat so as to protect this area. This disadvantage needs to be balanced against the previously discussed advantages in deciding on whether to utilize pressure.
  • the epidermis and dermis above the lipid-rich tissue being treated be cooled at least prior to, and preferably both prior to and during, the application of the radiation to minimize thermal damage to tissue in these areas.
  • the cooling not extend to the lipid-rich tissue being treated since such cooling would impede the treatment of this lipid-rich tissue and may prevent the desired treatment thereof. Therefore, when the sebaceous gland is being treated, cooling should not extent below or much below the DE boundary layer 18, and certainly should not extend much beyond 1 mm from the skin surface. Where subcutaneous fat 16 is being treated, the cooling may extent several millimeters into the dermis, depending on the thickness thereof.
  • the cooling may be performed in the manner indicated in the before-mentioned patents or by other techniques known in the art.
  • cryogenic cooling may be utilized to cool the skin to a predetermined depth prior to irradiation, or contact piece 32 may be cooled by flowing water or gas, or preferably by - 15 - semiconductor Peltier effect cooling as taught in co-pending application S.N. 08/759,136.
  • the temperature of for example contact piece 32 and the time during which this piece is in contact with the skin prior to irradiation will be primary factors in determining the depth of cooling.
  • the energy or fluence required to heat to a desired temperature and/or destroy targeted fat and the duration of the light pulses used for this purpose will vary, sometimes significantly, with the individual being treated, the area of the body being treated, the specific lipid-rich/fat tissue which is to be treated and the wavelength utilized.
  • a fluence of approximately 10 J/cm 2 to 500 J/cm 2 applied for a duration of approximately 10 ms to one second depending on the size of the gland should result in destructive heating or other treatment of sebaceous glands in most instances, particularly if the pressure and cooling procedures discussed in the preceding paragraphs are followed. Higher fluencies are required if shorter wavelengths are used (for example 920 nm or 1200 nm) because of the lower absorption coefficient of fat at these wavelengths.
  • wavelengths such as 1715 nm, or 2300 nm may be utilized for targeting of a sebaceous gland 22 or for treatment when the light source is adjacent the lipid-rich tissue, for non-invasive treatment of subcutaneous fat, particularly in region where the dermis is 3 to 4 nm thick
  • the high absorption of water at these wavelengths effectively prevents radiation at these wavelengths from penetrating to reach the subcutaneous fat layer, even when relatively high fluence signals are utilized.
  • the shorter wavelengths for example 920 nm or 1200 nm, water is significantly less absorbent, permitting a significant percentage of the applied radiation to reach at least the upper level of subcutaneous fat layer 16.
  • fat also has a significantly lower coefficient of absorption at these wavelengths than at the higher preferred wavelengths, meaning that more energy must be applied to the fat in order to achieve the same level of heating. For example, almost 10 times the energy must be applied to the fat at 920 nm as at 1200 nm in order to achieve the same heating of the fat, and the heating increases by nearly another six times for the same energy at 1715 nm. At 2300 nm, the energy absorbed is about five times greater than at 1715.
  • the mechanism by which the fat is destroyed or otherwise reduced will vary to some extent with the duration of radiation pulses and the temperature to which the fat is raised. If the fat cell temperature is raised slightly from body temperature of about 37°C by for example less than 10°C, no lethal injury occurs to most of the cells. This temperature rise does however initiate a biochemical reaction or lipolysis in the fat cells causing the cells to metabolize fat, or accelerate the metabolization thereof, thereby reducing the level of fat. At higher temperatures, for a sufficient duration, depending on size, fat cells are killed. As with most dead cells, the body ultimately absorbs and disposes of these cells.
  • liquid lipid contains free fatty acid which, in sufficient quantity, can be toxic to the human body. Therefore, if a substantial pool of liquid lipid is formed in this way, it is preferable that a hypodermic needle be inserted into this pool and that at least most of the liquid lipid be removed through the hypodermic needle so as to limit the amount thereof which is absorbed into the body.
  • the blebed cells would generally only extend for a few millimeters into the subcutaneous fat layer, for example 2 to 3 mm. Pooled liquid lipid may also be removed by perforating the skin above it and permitting it to drain or by facilitating drainage by manipulation/massage of the area or other techniques known in the art.
  • the advantage of the above procedure is that, so long as the temperature is kept low enough, for example below approximately 70°C or other collagen damage threshold, there will be no damage to the collagen bands which hold the skin to the body, and in fact these bands may be contracted by the heat. This maintains skin tone, notwithstanding the removal of the underlying subcutaneous fat and reduces sagging skin or dimples in the treated skin area. While - 17 - if the temperature of fat cells was raised high enough, the lipid could be melted, eliminating the need for the body to either absorb it or for it to otherwise be removed, and such procedure is also within the contemplation of the invention, it is not currently believed to be a preferred procedure because of the damage to the collagen bands in the subcutaneous fat layer and other problems which might occur at these elevated temperatures.
  • a possible procedure when using the teachings of this invention for ablating subcutaneous fat would be to place a cooling hand piece 32 in contact with the patient's skin, probably under at least some pressure, for a time sufficient to cool the skin to a desired level, perhaps 5 to 10 seconds. Because of hot blood flowing through the dermis, cooling generally levels off after roughly this duration and cooling to greater depth is not achieved.
  • the radiation source for example the laser
  • the radiation source is activated for an appropriate period of time, perhaps 1 to 100 seconds.
  • the required fluence and pulse duration can be calculated or can be determined empirically by using microwave or ultrasonic depth measuring techniques or other techniques known in the art for measuring temperature at depth.
  • Another option is to insert a needle into the area where a liquid lipid pool should be formed if the heat was sufficient to bleb the cell membranes to see if a liquid pool has been formed. If a liquid pool has not been formed, then treatment is required at either a higher fluence or for longer duration. This procedure can be repeated until liquid lipid is obtained.
  • the area from which the liquid lipid is being removed may be manually manipulated or "milked" to facilitate the removal of the liquid lipid pool.
  • the head used for applying radiation should preferably utilize a photorecycling technique, such as that taught in U.S. Patent No. 5,824,023 or in co-pending application Serial No. filed March 12, 1999.
  • a photorecycling technique such as that taught in U.S. Patent No. 5,824,023 or in co-pending application Serial No. filed March 12, 1999.
  • another way of more efficiently getting energy to an area under treatment is to pinch a fold of skin containing the treatment area in a section of the radiation emitting head, facilitating the application of radiation to the treatment area from at least two directions.
  • Such techniques are taught, for example in U.S. Patent No.
  • Fig. 2B illustrates an embodiment 36 of the invention which practices this pinched-fold technique.
  • the head - 18 - is formed of an optically transparent dielectric material 37 such as sapphire or glass and has a plurality of optical fibers 38 affixed thereto or embedded therein which fibers are angled to impinge on a fold of skin 39 drawn into a recess 41 formed in material 37. Recess 41 might for example be ! inch across.
  • the head and recess may be relatively shallow with only the fibers 38 shown in the figure or the head and recess may extend for a selected width into Fig.
  • a hole or groove 43 is provided to which negative pressure or vacuum may be applied to draw the fold of skin into groove 41 and a high reflecting coating 45 may be applied to the outer surface of material 37.
  • Coating 45 is effective to retroreflect radiation exiting skin fold 39 back into the skin in a manner discussed in the prior patent/application to enhance energy efficiency, thus permitting more radiation to reach a desired site for the same energy from a radiation source.
  • Optical fibers 38 can be angled to target a desired lipid-rich tissue region in fold 39.
  • ⁇ T temperature rise required from normal body temperature of approximately 37 °C to achieve lipid heating in accordance with the selected technique discussed above
  • d is the size of the targeted lipid region, for example the diameter of a sebaceous gland or the depth in for example subcutaneous fat or fat surrounding an organ, vessel or the like which is to be targeted
  • ⁇ f I is a thermal relaxation time of the fatty tissue targeted
  • is pulse width
  • ⁇ f absorption coefficient of the fatty tissue
  • p f density of the fat
  • c f heat capacity of the fat.
  • Thermal relaxation time for fatty tissue can vary from several nanoseconds for lipid in the membrane of a cell, to seconds (for example for a sebaceous gland), to several hours (for example for subcutaneous fat). - 19 -
  • the fluence required to be applied to the skin for a wavelength of 920 nm is 50-500 J/cm 2
  • the fluence required to be applied to the skin at 1200 nm is roughly 10-100 J/cm 2
  • the fluence for 1715 nm is 1 -50 J/cm 2 .
  • the low value in these ranges assumes the fat to be treated at substantially the skin surface with the fluence increasing as the depth of the fat being treated increases, the highest value being for subcutaneous fat at a depth of approximately 4 mm.
  • pulse duration is longer than the thermal relaxation time of the fat cells or tissues being heated, this being sometimes referred to as quasi-stationary heating
  • power densities required for selective damage of or initiation of biochemical processes in the fatty tissue are estimated to be in the following range: 920 nm: 500-2000 W/cm 2
  • the first three of these values are taken at the skin surface, while the last one is taken at the surface of the lipid tissue.
  • the sebaceous gland 22 has been targeted for destruction as a treatment for acne
  • the sebaceous gland being located close to the stem cells 25 of a hair follicle 20
  • the fat in the sebaceous gland could serve as a chromophore which is preferably heated by radiation at one of the selected wavelengths, the heat from the sebaceous gland if at a relatively low level being sufficient to sever the hair shaft at the level of the sebaceous gland, which hairs may then be washed away. This would be the equivalent of a shave which might last several weeks.
  • papilla or bulb 23 is located in the upper regions of subcutaneous fat 16. Therefore, heating subcutaneous fat in the region of a hair follicle in the manner previously discussed will also result in a heating of the bulb/papilla of the hair follicle which can damage or destroy these structures. Damage or destruction of the bulb or papilla is another mechanism by which hair removal is effected.
  • the teachings of this invention may also be utilized to target lipid-rich tissue in other regions for other purposes.
  • the stratum corneum contains a layer of lipid tissue which serves as liquid barrier in a persons epidermis.
  • This liquid barrier can reduce the effectiveness of needless injections which rely primarily on pressure to inject a liquid agent into the patient.
  • a short burst of radiation at one of the wavelengths indicated above, for example 1715 nm or 2300 nm, could remove this lipid barrier in the area where the injection is to be made just prior to the injection to enhance the effectiveness thereof.
  • the membranes walls of many cells are composed substantially of lipid and that these membranes differ somewhat from cell to cell.
  • Radiation at one of the wavelengths indicated above may therefore be effective to selectively porate cells, the selectivity being achieved either as a result of controlling the focusing of the radiation to a targeted region and/or certain of the cells in the region porating at lower fluence or less time of radiation application than others as a result of cell size, wall thickness and/or other factors.
  • Poration may be done for example to permit a drug or other therapeutic agent to enter the cell for healing or destruction thereof, for example, for the destruction of cancer cells, or to permit the content of the cell to flow out for various purposes.
  • the poration may be temporary, or may be permanent resulting in cell destruction.
  • lipid could be targeted in other areas as a chromophore for the heating and either the destruction or therapy on other body components.
  • heating of lipid may be used to shrink collagen for wrinkle removal or skin toning or the lipid layer in the stratum corneum may be targeted for other purposes.
  • Fat surrounding nerves, blood vessels or other biological structures may also be target for heating and treating the underlying structure.
  • the radiation - 21 - wavelength, intensity, and pulse duration would in each instance be adjusted based on the size of the lipid structure being targeted, its depth, the wavelength utilized, and other factors.
  • Fig. 3 illustrates a technique which may be employed to treat subcutaneous fat either in areas where the dermis is too thick for treatment to be performed from the skin surface as shown in Fig. 2, where treatment is desired at depths in subcutaneous fat layer 16 which are too deep for treatment from the skin surface, where it is desired to operate at one of the more efficient longer wavelengths which do not normally penetrate to the subcutaneous fat, or for other reasons.
  • a probe 40 is inserted through epidermis 12 and dermis 14 into subcutaneous fat region 16. Probe 40 may be a needle, or an opening may be formed in the skin through which a trocar or other cannula may be inserted, the probe 40 then passing through the cannula or trocar to the desired location. Other techniques known in the art for positioning a probe in subcutaneous fat region may be employed.
  • Probe 40 can contain an optical fiber or fiber bundle through which optical radiation at the wavelengths previously indicated may be applied to the end of the probe.
  • the end of the probe may be formed to either direct the light straight ahead, to direct the light at some angle to the direction of the probe or to direct the radiation in more than one direction.
  • a dispersive lens might also be employed at the end of the needle to expend treatment area.
  • a relatively large area of subcutaneous fat may be treated by a single insertion of the probe by moving the probe in and out of the subcutaneous fat and possibly by also rotating the probe about the entry point.
  • the probe may also be rotated to cover a larger area.
  • a larger area can be covered, though at a shallower depth.
  • a smaller area to a greater depth can be covered by inserting probe 40 at a sharper angle.
  • a cannula could be included around the optical fiber in probe 40 to remove this liquid on a periodic or continuous basis, or the pool could be removed in the manner previously discussed. While the procedure of Fig.
  • 3 may be used for any part of the body where fat is to be removed, it may be particularly advantageous for areas with smaller pockets of fat such as the face or neck. Further, while several techniques have been taught above for applying radiation within a preferentially absorbed wavelength band to subcutaneous - 22 - fat for the treatment thereof, other techniques, including various surgical techniques, could be utilized for reaching selected regions of subcutaneous fat in appropriate situations.
  • the teachings of this invention might be advantageously employed is to remove fat covering vessels, organs, or other anatomical elements on which a surgical procedure is to be performed so that the surgical procedure may be more accurately and safely performed with better visibility.
  • the tool for removing the fat might be inserted through a surgical opening or might be part of an endoscope or other tool inserted through a body cavity.
  • the tool inserted could be similar to probe 40 and, to minimize damage to surrounding tissue, is preferably placed in contact with the fat to be treated, or at least in near contact with such fat, for irradiation.
  • the tool is shown as a probe 50 inserted through a catheter 52 to the fat 54 surrounding a vessel, gut or other vital structure 56 to be surgically treated.
  • Catheter 52 could also include a standard probe to permit viewing of the area under treatment so that catheter 52 can be repositioned and treatment can be continued until a sufficient amount of the fat 54 has been removed to expose vessel 56. Where larger surgical incisions are made, the tool for removal/treatment of fat 54 from vessel 56 might be hand held by the surgeon and manipulated by him to remove fat.
  • fat 54 preferentially absorbs radiation at the applied wavelengths, and strongly absorbs at the higher wavelengths usable where there is substantial contract between the probe and the fat to be treated, the treatment of fat 54 should result in little if any thermal damage to underlying vessel 56 and, particularly if the wavelength is at approximately 1715 nm, or 2300 nm, this danger will be significantly reduced from prior art procedures were the radiation utilized was not preferentially absorbed by the fat tissue. More specifically, the fluence and exposure duration can be adjusted to ablate or otherwise treat fat, but not the nearby or underlying non-fat tissue.
  • a technique has thus been disclosed for the targeting of lipid-rich or fat tissue to effect a desired treatment by the selective application of optical radiation to such fat tissue at a wavelength preferentially absorbed thereby.
  • the fat tissue for targeting has been discussed above, including the sebaceous gland, subcutaneous fat and fat surrounding anatomical elements on which surgical procedures are to be performed, the invention is not limited to targeting only such fat tissue, but may be employed for the targeting of any lipid-rich tissue.
  • specific hardware has been described for producing radiation within the selected wavelength bands, other radiation sources capable of producing radiation within such bands might also be utilized.

Abstract

A method, and apparatus are provided for targeting lipid rich tissue to effect a desired method/apparatus involving irradiating the lipid rich tissue (16) with energy at a wavelength preferentially absorbed by lipid cells, such wavelength being preferably in a band between 880 nm to 935 nm, 1150 nm to 1230 nm, 1690 nm to 1780 nm, or 2250 nm to 2450 nm with a fluency, and duration sufficient to achieve a desired treatment. For preferred embodiments the irradiation wavelength is between 900 nm to 930 nm, 1190 nm to 1220 nm, 1700 nm to 1730 nm, or 2280 nm to 2350 nm. The method, and apparatus may for example be used to target one or more sebaceous glands (22) for the treatment of acne or hair removal to target subcutaneous fat for removal thereof, or for targeting fat on an anatomical elements for various purposes.

Description

- 1 -
METHOD AND APPARATUS FOR THE SELECTIVE TARGETING
OF LIPID-RICH TISSUES Related Applications
This application claims priority from provisional specification 60/079710 filed March 27, 1998, the subject matter of which is incorporated herein by reference.
Field of the Invention
This invention relates to methods and apparatus for the selective heating of lipid-rich tissue including sebaceous glands, subcutaneous fat, lipid in membranes of cells, and fat surrounding organs, vessels, hair bulbs, and other anatomical elements, and/or to the selective destruction or removal of such tissue and/or structures adjacent thereto; and more particularly to methods and apparatus for using optical radiation in selected wavebands, which radiation may be obtained from a laser or other suitable light source, to effect such heating, removal and/or destruction.
Background of the Invention Adipose or lipid-rich tissue, which is also sometimes referred to as "fat" or "fatty tissue", is a common cosmetic and surgical problem, and excessive body fat may also pose certain other health risks. Many factors, including heredity, glandular function, nutrition and lifestyle affect both the extent and location of body fat. Despite dieting and exercise, many people cannot lose fat, particularly in certain areas. Heretofore, liposuction, a procedure in which fat is removed by a suction cannula under local anesthesia, or other forms of fat excision have been used. Fat also occurs in pads on the face and neck and small area local liposuction has sometimes been performed in these areas. However, liposuction is an invasive surgical procedure and presents all of the disadvantages and risks to the patient involved in such a procedure, including scars at the sites of entry into skin. Another problem with liposuction is that it is not selective in only removing unwanted fat, but also rips out tissue in the path of the liposuction hose, including the collagen supporting structure holding the patient's skin in place. This can result in cosmetically unattractive sagging skin in the treated area, in addition to significant pain to the patient both during and after the procedure, risk of infection and other potential problems. The trauma caused by extreme liposuction has in some cases even resulted in the death of the patient. Further, while liposuction can be used for the removal of deep fat, it is significantly less - 2 - effective for removing fat at a superficial level of subcutaneous fat just below the dermis. Such removal is desirable in some cases because it is less traumatic to the patient. However, it is difficult to do with a liposuction cannula without scratching the dermis, damage to the dermis not healing readily, and attempts to perform surface liposuction also result in an uneven removal of fat which leaves an esthetically unattractive patterning on the patient's skin. Therefore, while liposuction is still used extensively for the removal of excess fat, it is not a desirable procedure.
Fat is also a problem in various surgical procedures where it may be difficult to locate vessels, organs or other anatomical elements on which surgery is to be performed when these elements are covered in fat, and it may be difficult to close surgical openings in such elements. Performing surgery on vessels, organs or other elements covered by fat is therefore risky and current procedures for removing such fat to facilitate surgical procedures have significant limitations. Of particular concern is mesenteric fat which is a common hindrance in laparoscopic surgery. With the current trend of making surgical procedures less invasive by inserting tools through a small surgical opening, the removal of fat in the region where a surgical procedure is being performed, utilizing a tool consistent with such surgical procedures, so as to facilitate remote viewing of the anatomical element being treated/operated on is therefore becoming increasingly important.
In addition, a major problem for teenagers and others is acne which originates at least in part from obstruction of outflow from a sebaceous gland. Certain drug treatments for acne operate through a mechanism of decreasing sebaceous gland output. Destruction, removal, or unblocking of the sebaceous gland, which gland contains lipid-rich tissue, in a non-invasive manner are therefore desirable alternatives for treatment or prevention of acne.
Another related problem is the removal of unwanted hair, and in particular the long-term or permanent removal of such hair by the damage or destruction of the hair follicle. Many techniques have been employed over the years for this treatment, including electrolysis, waxing and treatments with various forms of radiation, including light. However, electrolysis is slow and both electrolysis and waxing are painful to the patient and seldom permanent. Various radiation treatments, particularly those involving light, work more effectively for patients having darker hair than for patients with light hair and various proposals have been made over the years to add a chromophore in some way to the follicle to facilitate such treatments. The use of such artificial chromphores has not heretofore been particularly successful. - 3 -
Other related problems involve either removing fat, for example in the stratum corneum, under certain conditions, for example when a pressure injection is to be given, selectively porating cells having lipid-rich walls to permit substances, for example therapeutic agents, to enter the cells or to permit the removal of wanted or unwanted substances therefrom or to otherwise heat or destroy lipid-rich tissue for various therapeutic purposes.
While lasers or other light sources have been proposed in the past for heating, removal, destruction (for example killing), photocoagulation, eradication or otherwise treating (hereinafter collectively referred to as "treating" or "treatment") of lipid-rich tissue such as subcutaneous fat, the lasers proposed for such procedures have operated at a wavelength where lipid-rich tissue has an absorption coefficient which is generally significantly less then than that for water. This presents several problems. First, lipid-rich tissue is radiation heated as a result of absorption in the tissue of radiation energy. Therefore, for wavelengths at which lipid-rich tissue does not absorb the radiation strongly, large amounts of energy must be applied to the tissue in order to obtain the requisite heating. However, in addition to significantly increasing the cost of the procedure, the need for high energy poses a danger of damage to surrounding tissue or the tissue through which the radiation passes, particularly since most such tissue is primarily composed of water which absorbs the radiant energy much more at these wavelengths.
This is a particular problem for subcutaneous fat which generally starts at a depth of at least 1 to 4 mm into a patient's skin, and may be deeper for some individuals or some body areas. Therefore, in order for the radiation to target to the subcutaneous fat to cause selective heating or destruction thereof, it must pass through several millimeters of tissue formed primarily of water. Since water preferentially absorbs at these wavelengths, most of the incident radiation is absorbed in the skin prior to reaching the subcutaneous fat and, since skin is a scattering medium, incident light is also scattered and reflected from the patient's skin, resulting in a very small fraction of the incident light reaching the subcutaneous fat. Therefore, due to both the small fraction of the applied energy reaching the subcutaneous fat and the low absorption of this energy by the fat, in order to get enough energy to the subcutaneous fat at these wavelengths to be effective, large amounts of radiation would need to be applied to the overlying epidermis and dermis. Since such high levels of radiation absorbed in the dermis or epidermis would cause significant thermal damage to these skin layers at the prior art wavelengths, treatment/destruction of fat cannot be performed through the skin, but must be performed by providing an opening, for example a surgical opening, through the skin to provide - 4 - direct contact with the fat tissue to be treated. Even when the radiation is applied directly to the fat tissue to be treated, high energy is required and great care must be exercised to avoid excessive radiation of surrounding or underlying tissue so as to minimize damage thereto. Other prior art fat treatment techniques, involving the use of either microwaves or ultrasound, either alone or in conjunction with liposuction, to melt or loosen the fat and to remove it or have it absorbed into the body, have either proved not to be effective for fat removal, have posed potential health hazards to patients, either actual or perceived, or have still involved invasive procedures, the risk of which have been discussed earlier.
A need therefore exists for an improved technique for heating and destroying, or otherwise targeting lipid-rich tissue, including, but not limited to, subcutaneous fat. sebaceous gland, lipid in membrane cells and fat covering anatomical elements on which surgical or other procedures are is to be performed, which does not suffer the limitations of prior art techniques, including liposuction. and which is significantly more selective than the prior art in the destruction of lipid-rich tissue over tissue containing water so as to safely achieve the desired effects on lipid-rich tissue in performing a therapeutic procedure.
Summary of the Inventions
In accordance with the above, this invention provides a method and apparatus for selectively targeting lipid-rich tissue to effect a desired treatment, the method/apparatus involving irradiating the lipid-rich tissue at an infrared wavelength at which the ratio of absorption of the radiation by lipid-rich tissue to absorption by water is 0.5 or greater, and preferably greater than one. In particular the irradiation is preferably at a wavelength between 880-935 nm, 1150 to 1230 nm, 1690 to 1780 nm, or 2250 to 2450 nm with a fluence and for a duration sufficient to treat such lipid-rich tissue. For preferred embodiments, depending on application, the irradiation wavelength is between approximately, 900 to 930 nm, 1190 to 1220 nm, 1700 to 1730 nm, or 2280 to 2360 nm, with approximately 920 nm, 1210 nm, 1715 nm, and 2300 nm being most preferred wavelengths. While the fluence and duration of irradiation will vary somewhat with the patient undergoing treatment, the anatomical location of the tissues being treated, the radiation source and wavelength, the size of the lipid-rich tissue being treated and other factors, for preferred embodiments the treatment fluence may for example be approximately 0.5 J/cm2 to 500 J/cm2, with the duration of treatment pulses being - 5 - approximately 10 μs to several seconds, or even minutes for photothermal effect, and less than 1 μs (i.e., generally 1 μs to 1 ns) for photomechanical effects.
Where the lipid-rich tissue being treated is one or more sebaceous glands, irradiating the tissue/gland is performed by applying the energy at an indicated wavelength, which wavelength is preferably in one of the higher bands, to the skin surface overlying such one or more sebaceous glands. Where the lipid-rich tissue is subcutaneous fat, energy may be applied to the skin surface overlying the subcutaneous fat to be treated. Where either the sebaceous gland or subcutaneous fat is treated through the overlying skin, and particularly for subcutaneous fat, the radiation is preferably applied through an applicator which applies pressure to the skin above the lipid-rich tissue being treated. This pressure reduces the distance from the radiation- applying applicator to the lipid-rich tissue being targeted, removes blood from the area above the fat tissue being targeted and compresses such overlying tissue to reduce scattering and enhance optical focusing of radiation on the treatment area. It is also desirable that the skin above the area being treated be cooled to a selected depth, which depth is above that of the lipid-rich/fat tissue being targeted. Thus, cooling could be deeper for the treatment of subcutaneous fat, where the cooling could be most of the way through the dermis, while the cooling would be to a much shallower depth, perhaps only to the dermis/epidermis (DE) junction, where the sebaceous gland is being treated. While radiation in the higher bands can be used, and may be preferable because of the higher absorption coefficient of fat in these bands, for treating the sebaceous gland which is relatively close to the skin surface, absorption by water at these wavelengths make it difficult to reach subcutaneous fat, and radiation in the lower bands, for example in 1150 to 1230 nm range where water is less absorbent may therefore be preferable for treating subcutaneous fat. In addition to or instead of pressure being applied to the skin, a fold of skin may be drawn into a recess in a radiation delivery head in a suitable manner and radiation applied to the recess from at least two directions. This has a number of beneficial effects, including reducing the distance from the radiation source to the lipid tissue, increasing the radiation at the desired depth without increasing radiation in regions above the target area and, where a retroreflection technique to be discussed later is utilized, substantially eliminating radiation loss as a result of the scattered radiation reflected from the patient's skin. Alternatively, to increase the local intensity for treatment of subcutaneous fat when delivered through the overlying skin, a convergent incident beam is advantageous to compensate for losses due to optical scattering and absorption in the dermis. - 6 -
While the sebaceous gland may be heated to destroy the gland as part of an acne treatment, the sebaceous gland may also be heated to cause destruction of adjacent areas of a hair follicle, for example the stem cells of the hair follicle as a treatment to achieve hair removal and impede regrowth. Radiation in the indicated wavelengths may also be applied selectively to cells having lipid-rich membranes to porate the membranes to for example permit selective drug delivery to the cells or for other purposes for lipid-rich cells or tissue may be otherwise targeted and heated for affecting some other therapeutic function. Since the radiation fluence, pulse duration, wavelength and other factors may be carefully controlled, and the area to which the radiation is directed may also be controlled, selective lipid-rich cells may be non-invasively targeted to achieve the above and other therapeutic affects.
Where subcutaneous fat is being non-invasively treated, duration of radiation pulse and the temperature to which the fat or lipid tissue is heated are critical to the desired results. For example, at increased temperature, fat is altered by a biochemical reaction or lipolysis, while for higher temperatures and sufficient pulse duration, fat cells are killed, permitting the cells and liquid lipid therein to be absorbed. At still higher temperatures, cell membranes are destroyed, permitting lipid pools to be formed. These pools may also be absorbed but, since free fatty acid in lipid can be toxic in sufficient quantity, if substantial quantities of fat cell membranes have been destroyed, permitting a large lipid pool to be formed, it is preferable to remove the lipid, for example with a cannula or needle. The heated collagen of supporting structure may react to provide a more pleasing skin appearance after treatment and avoid sagging folds of skin or skin depressions where the lipid tissue has been destroyed. While all of the fat in a subcutaneous layer may be treated, it is difficult to get sufficient energy deep into the fat, so treatment is generally restricted to a surface layer of the fat. Repetitive treatments may be performed to remove successive layers of the subcutaneous fat. While non-invasive procedures are preferable, subcutaneous fat may also be treated by passing a probe through the skin to the subcutaneous fat to be treated. The probe, which may for example be a needle, may be passed into the subcutaneous fat at an angle to the skin surface and the probe may be moved both in an out of the skin and rotated about its skin entry point to irradiate and treat subcutaneous fat over a selected area. This needle or probe may also contain a cannula for removing liquid lipid pooled as indicated above from the radiation treatment
Where lipid-rich tissue/fat surrounds a vessel, organ or other anatomical element on which a surgical or other procedure is to be performed, the irradiation may be performed by use - 7 - of a tool which is in at least near contact, and preferably in contact, with the fat to be treated, the element treating the fat to expose the anatomical element on which the procedure is to be performed. Because radiation for this embodiment does not need to pass through water rich tissue to reach the fat, wavelengths in the higher bands would normally be used for this procedure.
While various light sources might be utilized to obtain optical energy within the required bands, and in particular at the preferred wavelengths, including a suitably filtered tungsten lamp, an optical parametric oscillator, a Raman convertor or shifter, a color center laser or a tunable dye laser, the preferred light source at the desired wavelengths is a diode laser or lasers with flashlamp or diode pumping which will be described in greater detail later.
The foregoing and other objects, feature and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention as illustrated in the accompanying drawings:
In the Drawings
Fig. 1 is a diagrammatic sectional view of human skin illustrating both a hair follicle with a sebaceous gland and subcutaneous fat.
Fig. 2A is a sectional view illustrating an area of subcutaneous fat under treatment in accordance with the teachings of a first embodiment of this invention. Fig. 2B is a sectional view illustrating an area of skin, either subcutaneous fat, sebaceous gland or other targeted lipid-rich tissue, under treatment in accordance with an alternative embodiment of the invention.
Fig. 3 is a sectional view illustrating a section of skin with subcutaneous fat under treatment employing another alternative embodiment of the invention. Fig. 4 is a sectional view illustrating a tool being utilized to clear fat from a vessel on which a surgical procedure is to be performed in accordance with the teachings of this invention.
Fig. 5 is a graph illustrating the coefficient of absorption of water and of human fatty tissue as a function of wavelength. Fig. 6 is a graph illustrating the ratio of human fatty tissue coefficient of absorption to water coefficient of absorption as a function of wavelength. - 8 -
Detailed Description
Fig. 1 is a simplified sectional view through a piece of human skin 10 illustrating the major skin layers. The outermost layer is the epidermis 12 which overlies the dermis 14. Under the dermis is a layer of subcutaneous fat 16. The epidermis is typically relatively thin, on the order of 0.1 mm, although this thickness varies for different parts of the body, with the lower portions of the epidermis near the DE junction 18 containing quantities of melanin which vary with the pigmentation of the individuals skin. The thickness of dermis layer 14 varies from approximately 1 to 5 mm depending on the part of the body and on the individual, and may be thicker in some instances. The lower third of the dermis typically contains numerous lobules of fat. Subcutaneous fat 16, which may be several centimeters thick, therefore generally starts at a depth of a little less than 1 mm to approximately 4 mm from the skin surface.
Fig. 1 also illustrates a single hair follicle 20 with an adjacent sebaceous gland 22. Hair follicle 20 has a bulb or papilla 23 and stem cells in a bulge region 25, both of which are involved in the growth and regrowth of hair from the follicle. Sebaceous glands 22 are formed primarily of fat/lipid-rich tissue. The cells lining the outer portion of sebaceous glands are called sebocytes. These cells migrate inward, synthesizing a lipid-rich fluid called sebum as they differentiate and finally are shed. The sebum flows outward through a duct into the infundibulum ("pore") of the follicle. The greasy, oily material which accumulates on the surface of skin is sebum, after flowing out of numerous follicles. When the outflow from a sebaceous gland becomes clogged, it may result in the formation of an acne pimple. This is a particular problem for larger sebaceous glands, for example those on the face and upper back, which are the most common sites of acne. Sebaceous glands are typically found approximately 1 mm below the skin surface, although they may be at greater depths in some instances, and are in the dermal layer 14 as shown in Fig. 1. While as was discussed earlier, various techniques have been used in the past to remove unwanted fat, and there has been limited use of lasers for treating fat tissue, since there was not selective absorption by lipid-rich tissue for the wavelengths at which such procedures were conducted, such fat treatment could generally be done only through a surgical procedure which permitted the laser to be brought directly adjacent or in contact with the fat tissue to be treated. However, because of the low absorptions of fat at such wavelengths, and the high ratio of water absorption to fat absorption, very high energy was required for treatment and extreme care had to be exercised so as to avoid unintended damage to other tissue either adjacent to or underlying - 9 - the fat tissue to be treated. As a result, such procedures have not been used to any significant extent.
In order to determine a preferential wavelength for lipid absorption, it should be appreciated that the temperature rise in a given tissue as a result of absorbing a given amount of energy is a function of the density of the tissue and its heat capacity. When this temperature increase for absorbed energy is compared for water and fat or lipid-rich tissue, it is found that the temperature rise in the lipid-rich tissue for a given energy absorption is 1.8 to 2 times that for water. Therefore, lipid-rich tissue need absorb 0.5 to 0.6 as much energy to achieve the same temperature rise as for water. Thus, for purposes of the following discussion, it will be assumed that lipid tissue preferentially absorbs at a wavelength for which the coefficient of absorption for fat is at least 0.5 that of water, although this ratio for preferred wavelengths is at least 1 and is 1.5 or higher for selected wavelengths.
Thus, as illustrated in Figs. 5 and 6, and in accordance with the teachings of this invention, it has been discovered that for wavelengths between approximately 880 nm and 935 nm, 1150 and 1230 nm, 1690 and 1780 nm, or 2250 and 2450 nm, lipid has at least 0.5 the absorption of water, and generally greater absorption than water, water being the major constituent of lipid-poor tissue. This absorption is attributed to a vibrational mode in the C=H and C-H bands common in lipids. These wavelength bands also are readily compatible with silica optics. For these regions, the absolute absorption by both water and lipid increases with increases in the wavelength (i.e., both water and lipid absorb most strongly in the 2250 to 2450 nm range and absorb least strongly in the 900 to 930 nm range). The ratio of lipid absorption to water absorption is also greater for the higher wavelengths, being over 1.5 for maximas at approximately 1715 nm and 2300 nm. Therefore, radiation within the above-indicated wavelength bands, and in particular radiation at or near various maxima in these bands such as 925 nm, 1210 to 1230 nm, 1715 nm, or 2300 nm would be particularly effective for treating lipid-rich tissue such as sebaceous glands or subcutaneous fat. However, the depth which light/radiation reaches in a patient's skin is inversely proportional to light absorption above such depth. Since water is the primary constituent of skin tissue, water absorption is a controlling factor in the depth which radiation of a particular wavelength may reach in a patient's skin. Therefore, radiation in the 900 to 930 nm band and 1210 to 1230 nm band which are most weakly absorbed by water, while still being at least somewhat strongly absorbed by fat, are the currently preferred radiation bands for non-invasively treating subcutaneous fat, where the - 10 - radiation generally needs to reach at least 3 to 4 mm within the patient's skin. However, radiation in the higher bands, and particularly at 1200 nm (with focusing), 1715 nm, and 2300 nm wavelengths, may be preferable for treating the sebaceous gland which is generally located only 1 mm into the patient's skin, since fat absorbs more strongly at these wavelengths and water absorption in the overlying skin is not as big a factor. The longer wavelengths could also be used where a suitable light emitting probe is positioned adjacent the fat to be ablated, for example to clear fat from a vessel, organ or the like or where a needle is used to get to subcutaneous fat.
The first issue in implementing the teachings of this invention is to find a radiation source adapted for generating sufficient radiation at the required wavelengths. Unfortunately, while commercially available lasers or other radiation sources are available for the 900-930 nm range and YAG lasers operate at approximately 1060 and 1300 nm, current commercially available lasers/radiation sources are not normally adapted for generating radiation at the other preferred wavelengths. However, there are lasers and other radiation sources suitable for generating such radiation.
For example, the following light sources with wavelengths around 920, 1200, 1715, or 2300 nm can be used for fatty tissue targeting:
1. Tungsten lamp or an arc lamp with an absorptive or reflective filter which filters the required spectral region. Optimum lamp temperature is in the region 1300-2000 K. 2. Tungsten lamp or an arc lamp with a luminescence filter with a peak of luminescence at one of the spectral regions described above. As a filter, the following can be used: crystals with color centers, liquid dyes or dyes in a solid matrix.
3. Diode lasers, such as GaAs (920 nm), AlGaSbAs (1200, 1215 nm), InGaAsP/InP (1715 nm), InGaAs (2300 nm). 4. Lasers based on crystals with color centers and lamp or laser pumping. These would include crystals NaF with F2+ centers (1200 nm) or KC1 with F2+ centers (1215 nm) or KClLi with F2+ centers (2300 nm).
5. Lasers with non-linear wavelength conversion; optical parametric oscillators (OPO) or Raman converters can be used as such non-linear converters. Solid state lasers can be used for pumping (Nd laser, Ho laser, Er laser, fiber laser etc.) of OPO or Raman converter. - 11 -
6. One of the most effective lasers can be a lamp pumped solid state laser with correct spectral lines. For example crystals with ions Er3+ can generate in the region 1200 nm (4S3/2-> 4I11/12) and 1715 (4S3/2→%/2).
For operating in the 1700 to 1730 nm range, one suitable laser is a potassium cadmium laser with the matrix KCd(WO4)2 which is doped with Er3+(erbium) ions. The concentration of Er3+ ions should be in the range of 1-10 percent, with the optimal concentration being approximately 2-5 percent. The energy level transition 4S3/2-44I9/2 should be used for laser generation. For both levels 4S3/2 and 4I9/2, Stark broadening and the wavelength for maximum laser output depend on the relative orientation of the crystal axis, laser radiation axis and polarization of laser radiation. When the orientation is such that the axis of the laser beam is at an angle greater than 45 degrees with the crystal line axis [010], the spectral maximum of the laser output is at the desired 1715 nm wavelength. Maximum efficiency is achieved when the axis of the laser beam lies in the plane determined by the crystalline axis [100] and [001] and is directed along the optical axis Nm which forms an angle of 24 degrees with crystalline axis [100]. If the same crystal is used for laser generation along the crystalline axis [010], the wavelength of laser generation for the same transition is 1730 nm. Flashlamps, laser diodes, other lasers or other pump mechanisms can be used to pump the above crystal in order to achieve the desired wavelength output.
In order to obtain maximum efficiency, the following scheme might be used to provide the desired radiation:
A diode laser generating an output at approximately 920 nm is used to pump a Yb doped glass or fiber with a laser wavelength of 1100 nm. This output is then frequency-doubled to obtain a wavelength of 550 nm which is the most efficient pumping wavelength and may be utilized for direct pumping of the 4S3/2 level. The maximum efficiency would be 0.6 (diode) x 0.3 (fiber laser) x 0.7 (doubling) x 0.3 (Er laser) = 3.75 percent. With this laser, it is possible to achieve generation of wavelengths 850 nm (4S3/24I!3/2 transition) and 1220 nm ( 4S3/24I,1/2 transition), along with the generation at wavelengths 1715 nm or 1732 nm. The laser can work simultaneously at various combinations of these wavelengths including: λ = 1715 nm and λ = 850 nm, or λ = 1715 nm (λ = 1730 nm) and λ = 1210 nm, or λ = 1715 nm (λ = 1730 nm), λ = 1210 nm and λ = 850 nm. - 12 -
Laser light from pumping diode laser (920 nm) can also be used for selectively heating fat. Control over the spectral distribution is achieved by changing mirrors or by a dispersive element inside the laser cavity.
Radiation at 1730 nm, may be obtained if lasers based on YLF, YAG, YAL. YSGG or a fiber doped with Er3+ ions are used. In these lasers, the same transition where 4S3 2-*4I9/2 is used, and the ion concentrations and the pumping methods would be substantially the same as for the preferred laser indicated above, but as indicated previously, would result in an output at 1730 nm, which is not one of the most optimal wavelengths for lipid-rich tissue ablation, although still suitable for this purpose. Its combination with λ = 1210 nm and λ = 850 nm is also possible. Pumping methods and concentration of active ions is the same as for the KCd(WO4)2:Er3+. The concentration of EX ions should be in the range 1-50%, with an optimal ion concentration being in the range 2-5%.
Radiation at 1730 nm may be achieved using for example, an YLF:Er3+ with concentration of Er3+ 25% laser with flashlamp pumping. For this laser, the maximum output energy is 1 J, slope efficiency is 0.5 %, repetition rate is 4 Hz and the pulse width is 0.4 ms.
Certain diode lasers may also be utilized to generate radiation within the desired wavelength ranges. For example, a laser based on InGaAsP/InP can generate laser output in a range of wavelengths about 1700 nm with fine temperature tunability and stabilization.
Blackbody sources, such as a tungsten lamp with suitable optical filters, can also be used to produce the desired radiation. However, the spectral power and tissue selectivity of such light sources would be less than for laser sources. The optimal temperature of the heat source should be about 1700 degrees K, with approximately 5 percent of the radiation of the lamp operating at this temperature being in the spectral region between 1700 nm and 1760 nm. Further, while the desired wavelengths can also be achieved by a tunable laser like a dye laser, free electron laser, color center laser or Raman shifter, the efficiencies of these lasers is low and they are very expensive. They are therefore not as practical as other sources for this application. Finally, an optical parametric oscillator (OPO) with pumping from a solid state laser or a fiber laser could also generate energy at the desired wavelengths. An OPO has maximum efficiency only for very short pulses, and would be most useful therefore when treatment is accomplished by photomechanical or photodissociation at 1 ns to 4 fs interactions. Other light sources generating radiation within the indicated wavelength band might also be utilized in appropriate applications. - 13 -
The time of exposure at a given site can be effectively used over a very wide range, but is preferably within either of two regions causing photothermal or photomechanical effects. For photothermal damage, or necrosis of lipid-rich tissues including fat and sebaceous glands, exposure durations of 0.1 ms to several minutes and sometimes higher are desirable, depending on the size of the targeted structure (for example the sebaceous gland diameter or subcutaneous fate depth being treated). For photomechanically-mediated damage, or necrosis, e.g. by violent castation, shock waves, or spallation, an exposure of less than 1 microsecond is desirable, and less than 10 μs is most preferred. The longer exposure duration can be generated for example by a flashlamp-pumped laser, scanned or shuttered CW laser, or conventional sources described above. The shorter exposure durations, less than 10 μs can be generated by Q-switching or mode-locking of laser cavities, or by an OPO or Raman-shifted Q-switched laser as described above.
Fig. 2 illustrates one way in which the teachings of this invention might be utilized to non-invasively treat either subcutaneous fat 16 (as shown in the figure), at least one sebaceous gland 22 or other targeted lipid-rich tissue. For this embodiment of the invention, an applicator 30, which could for example be of the type shown in U.S. Patents 5,595,568 or 5,735,844, is utilized. Applicator 30 may have a lens 32 or other suitable contact element at the front end thereof, which element is adapted to be in pressure contact with the upper surface of epidermis 12, thereby deforming the skin in the contact area for example as shown in Fig. 2. Applying pressure to the skin in this way provides a number of advantages. First, the pressure reduces the distance between the laser source and the sebaceous gland 22/ subcutaneous fat 16, thereby reducing the amount of tissue through which the light must pass prior to reaching the area under treatment. While radiation within the indicated bands is preferentially absorbed by the lipid- rich tissue, there is still absorption by the water/blood-containing tissue above the lipid-rich tissue being treated. Therefore, the greater the reduction in the quantity and thickness of this tissue, by for example tension, the less energy is lost in this tissue, resulting both in more energy being available for treatment at the desired location and in less heating, and therefore less potential thermal damage, to the lipid-poor tissue not under treatment.
The second advantage is that if the pressure is above the body's blood pressure (e.g., about 3 psi), the pressure will force blood out from under the applicator, further reducing absorption in the lipid-poor tissue through which the radiation passes. It has also been found that compressed tissue causes significantly less scattering of light energy passing therethrough, - 14 - or in other words is more transparent to such light energy, when under significant pressure than when not under such pressure. Not only does this phenomenon reduce radiant energy loss, and thus heating in the tissue above the tissue under treatment, but it also permits more effective focusing of light energy to facilitate heating and/or damage of only desired tissue. Thus, light could be focused to a depth of approximately 1 mm for treatment of lipid-rich sebaceous glands to for example treat an acne problem or for hair removal, and could be focused to a depth of for example 3 or 5 mm for treatment of subcutaneous fat 16. Fig. 2 shows an exemplary such focused radiation beam 34 being directed to the upper portions of subcutaneous fat layer 16. However, while applying pressure has some advantages, it is also disadvantageous in that blood flowing through the dermis is one effective way of removing heat so as to protect this area. This disadvantage needs to be balanced against the previously discussed advantages in deciding on whether to utilize pressure.
One problem with applying energy to the sebaceous gland 22 or to subcutaneous fat 16 through the overlying epidermis and dermal tissue is that, even though the overlying tissue do not preferentially absorb radiation at the indicated wavelengths, they do as can be seen from Fig. 5, and depending on wavelength, absorb significant radiation and can therefore become heated. Such heating can cause potential temporary skin damage or permanent scarring, with permanent scarring occurring primarily in the dermis 14. Blistering, peeling, and depigmentation are other potential adverse affects which may result from the heating of tissue above the lipid-rich tissue under treatment.
Therefore, it is preferable that the epidermis and dermis above the lipid-rich tissue being treated be cooled at least prior to, and preferably both prior to and during, the application of the radiation to minimize thermal damage to tissue in these areas. However, it is also important that the cooling not extend to the lipid-rich tissue being treated since such cooling would impede the treatment of this lipid-rich tissue and may prevent the desired treatment thereof. Therefore, when the sebaceous gland is being treated, cooling should not extent below or much below the DE boundary layer 18, and certainly should not extend much beyond 1 mm from the skin surface. Where subcutaneous fat 16 is being treated, the cooling may extent several millimeters into the dermis, depending on the thickness thereof. The cooling may be performed in the manner indicated in the before-mentioned patents or by other techniques known in the art. In particular, cryogenic cooling may be utilized to cool the skin to a predetermined depth prior to irradiation, or contact piece 32 may be cooled by flowing water or gas, or preferably by - 15 - semiconductor Peltier effect cooling as taught in co-pending application S.N. 08/759,136. The temperature of for example contact piece 32 and the time during which this piece is in contact with the skin prior to irradiation will be primary factors in determining the depth of cooling. The energy or fluence required to heat to a desired temperature and/or destroy targeted fat and the duration of the light pulses used for this purpose will vary, sometimes significantly, with the individual being treated, the area of the body being treated, the specific lipid-rich/fat tissue which is to be treated and the wavelength utilized. For a sebaceous gland 22 having a diameter which is generally in the 0.5 to 3 mm range, which is typical for sebaceous glands being treated which are frequently larger sebaceous glands, a fluence of approximately 10 J/cm2 to 500 J/cm2 applied for a duration of approximately 10 ms to one second depending on the size of the gland, should result in destructive heating or other treatment of sebaceous glands in most instances, particularly if the pressure and cooling procedures discussed in the preceding paragraphs are followed. Higher fluencies are required if shorter wavelengths are used (for example 920 nm or 1200 nm) because of the lower absorption coefficient of fat at these wavelengths.
While because of the higher absorption of lipid tissue at the longer wavelengths, wavelengths such as 1715 nm, or 2300 nm may be utilized for targeting of a sebaceous gland 22 or for treatment when the light source is adjacent the lipid-rich tissue, for non-invasive treatment of subcutaneous fat, particularly in region where the dermis is 3 to 4 nm thick, the high absorption of water at these wavelengths effectively prevents radiation at these wavelengths from penetrating to reach the subcutaneous fat layer, even when relatively high fluence signals are utilized. However, at the shorter wavelengths, for example 920 nm or 1200 nm, water is significantly less absorbent, permitting a significant percentage of the applied radiation to reach at least the upper level of subcutaneous fat layer 16. However, as may be seen from Fig. 5, fat also has a significantly lower coefficient of absorption at these wavelengths than at the higher preferred wavelengths, meaning that more energy must be applied to the fat in order to achieve the same level of heating. For example, almost 10 times the energy must be applied to the fat at 920 nm as at 1200 nm in order to achieve the same heating of the fat, and the heating increases by nearly another six times for the same energy at 1715 nm. At 2300 nm, the energy absorbed is about five times greater than at 1715. However, beyond 1300 nm, substantially all energy applied to water-rich tissue is absorbed in passing through several millimeters of skin, and it is therefore very difficult, even with pressure, for radiation at these - 16 - wavelengths to be used for non-invasively targeting subcutaneous fat, except possibly in areas such as sacks under the eyes or in the neck where this fat may be closer to the surface. Therefore, it is currently contemplated that radiation in the band around 1200 nm is the best compromise between energy reaching the subcutaneous fat through the overlying tissue and the radiation being of a wavelength which is absorbed sufficiently by the fat tissue to cause a desired treatment to occur.
The mechanism by which the fat is destroyed or otherwise reduced will vary to some extent with the duration of radiation pulses and the temperature to which the fat is raised. If the fat cell temperature is raised slightly from body temperature of about 37°C by for example less than 10°C, no lethal injury occurs to most of the cells. This temperature rise does however initiate a biochemical reaction or lipolysis in the fat cells causing the cells to metabolize fat, or accelerate the metabolization thereof, thereby reducing the level of fat. At higher temperatures, for a sufficient duration, depending on size, fat cells are killed. As with most dead cells, the body ultimately absorbs and disposes of these cells. At still higher temperatures, for example above 60 °C, the walls or membranes of the lipid cells, which walls are primarily of lipid-rich material, are blebed, losing their ability to encapsulate the liquid lipid therein, the liquid lipid leaking therefrom to form pools which will also ultimately be absorbed by the body. However, liquid lipid contains free fatty acid which, in sufficient quantity, can be toxic to the human body. Therefore, if a substantial pool of liquid lipid is formed in this way, it is preferable that a hypodermic needle be inserted into this pool and that at least most of the liquid lipid be removed through the hypodermic needle so as to limit the amount thereof which is absorbed into the body. Typically, both because of the limited depth to which significant radiation can be applied in the subcutaneous fat layer and for other reasons, the blebed cells would generally only extend for a few millimeters into the subcutaneous fat layer, for example 2 to 3 mm. Pooled liquid lipid may also be removed by perforating the skin above it and permitting it to drain or by facilitating drainage by manipulation/massage of the area or other techniques known in the art.
The advantage of the above procedure is that, so long as the temperature is kept low enough, for example below approximately 70°C or other collagen damage threshold, there will be no damage to the collagen bands which hold the skin to the body, and in fact these bands may be contracted by the heat. This maintains skin tone, notwithstanding the removal of the underlying subcutaneous fat and reduces sagging skin or dimples in the treated skin area. While - 17 - if the temperature of fat cells was raised high enough, the lipid could be melted, eliminating the need for the body to either absorb it or for it to otherwise be removed, and such procedure is also within the contemplation of the invention, it is not currently believed to be a preferred procedure because of the damage to the collagen bands in the subcutaneous fat layer and other problems which might occur at these elevated temperatures.
A possible procedure when using the teachings of this invention for ablating subcutaneous fat would be to place a cooling hand piece 32 in contact with the patient's skin, probably under at least some pressure, for a time sufficient to cool the skin to a desired level, perhaps 5 to 10 seconds. Because of hot blood flowing through the dermis, cooling generally levels off after roughly this duration and cooling to greater depth is not achieved.
Once the precooling has been completed, the radiation source, for example the laser, is activated for an appropriate period of time, perhaps 1 to 100 seconds. The required fluence and pulse duration can be calculated or can be determined empirically by using microwave or ultrasonic depth measuring techniques or other techniques known in the art for measuring temperature at depth. Another option is to insert a needle into the area where a liquid lipid pool should be formed if the heat was sufficient to bleb the cell membranes to see if a liquid pool has been formed. If a liquid pool has not been formed, then treatment is required at either a higher fluence or for longer duration. This procedure can be repeated until liquid lipid is obtained. The area from which the liquid lipid is being removed may be manually manipulated or "milked" to facilitate the removal of the liquid lipid pool.
Since substantial fluence may be required in order to ablate subcutaneous fat in the manner indicated above because of both the energy loss in the overlying layers and the relatively low coefficient of absorption for the fat at the wavelengths which must be used to reach the subcutaneous fat, the head used for applying radiation should preferably utilize a photorecycling technique, such as that taught in U.S. Patent No. 5,824,023 or in co-pending application Serial No. filed March 12, 1999. In conjunction with photorecycling, another way of more efficiently getting energy to an area under treatment is to pinch a fold of skin containing the treatment area in a section of the radiation emitting head, facilitating the application of radiation to the treatment area from at least two directions. Such techniques are taught, for example in U.S. Patent No. 5,735,844 and in co-pending application S.N. , the contents of which are incorporated herein by reference. Fig. 2B illustrates an embodiment 36 of the invention which practices this pinched-fold technique. For this embodiment, the head - 18 - is formed of an optically transparent dielectric material 37 such as sapphire or glass and has a plurality of optical fibers 38 affixed thereto or embedded therein which fibers are angled to impinge on a fold of skin 39 drawn into a recess 41 formed in material 37. Recess 41 might for example be ! inch across. The head and recess may be relatively shallow with only the fibers 38 shown in the figure or the head and recess may extend for a selected width into Fig. 2B and additional fibers 38 may be provided at selected points along such width. A hole or groove 43 is provided to which negative pressure or vacuum may be applied to draw the fold of skin into groove 41 and a high reflecting coating 45 may be applied to the outer surface of material 37. Coating 45 is effective to retroreflect radiation exiting skin fold 39 back into the skin in a manner discussed in the prior patent/application to enhance energy efficiency, thus permitting more radiation to reach a desired site for the same energy from a radiation source. Optical fibers 38 can be angled to target a desired lipid-rich tissue region in fold 39.
While in the discussion above, required fluence has been more or less empirically determined, in some applications, the required fluence can be estimated by use of the following equation:
C ΔT
(1)
1 -β (l -e < rf)
Where P is power density, ΔT is temperature rise required from normal body temperature of approximately 37 °C to achieve lipid heating in accordance with the selected technique discussed above, d is the size of the targeted lipid region, for example the diameter of a sebaceous gland or the depth in for example subcutaneous fat or fat surrounding an organ, vessel or the like which is to be targeted, τf I is a thermal relaxation time of the fatty tissue targeted, τ is pulse width, αf is absorption coefficient of the fatty tissue, pf is the density of the fat and cf is the heat capacity of the fat. Fluence (E) is given by:
E=Pτ (2)
Thermal relaxation time for fatty tissue can vary from several nanoseconds for lipid in the membrane of a cell, to seconds (for example for a sebaceous gland), to several hours (for example for subcutaneous fat). - 19 -
Using the above equations, and assuming a temperature rise ΔT in the fat of approximately 13°C, to 50 °C, the fluence required to be applied to the skin for a wavelength of 920 nm is 50-500 J/cm2, the fluence required to be applied to the skin at 1200 nm is roughly 10-100 J/cm2 and the fluence for 1715 nm is 1 -50 J/cm2. The low value in these ranges assumes the fat to be treated at substantially the skin surface with the fluence increasing as the depth of the fat being treated increases, the highest value being for subcutaneous fat at a depth of approximately 4 mm. Since at the other preferred wavelength band, radiation applied to the skin will not normally reach subcutaneous fat, for this wavelength band it has been assumed that the radiation is applied directly or nearly directly to the fat cells, differences in range being accounted for by differences in size or depth of the lipid cells being treated, pulse width and the temperature to which the fat is to be raised. With these assumptions, at 2300 nm, the fluence range is 0.5-20 J/cm2.
Where the pulse duration is longer than the thermal relaxation time of the fat cells or tissues being heated, this being sometimes referred to as quasi-stationary heating, power densities required for selective damage of or initiation of biochemical processes in the fatty tissue are estimated to be in the following range: 920 nm: 500-2000 W/cm2
1200 nm: 50-500 W/cm2
1715 nm: 10-200 W/cm2 2300 nm: 5-50 W/cm2
The first three of these values are taken at the skin surface, while the last one is taken at the surface of the lipid tissue.
While in the discussion above, the sebaceous gland 22 has been targeted for destruction as a treatment for acne, the sebaceous gland, being located close to the stem cells 25 of a hair follicle 20, may be targeted for other therapeutic purposes. In particular, the fat in the sebaceous gland could serve as a chromophore which is preferably heated by radiation at one of the selected wavelengths, the heat from the sebaceous gland if at a relatively low level being sufficient to sever the hair shaft at the level of the sebaceous gland, which hairs may then be washed away. This would be the equivalent of a shave which might last several weeks. More intense targeting of the sebaceous gland could result in sufficient heating to destroy the stem cells of the follicle which could sufficiently damage or destroy the follicle to provide long term or even permanent hair removal. This technique would be particularly advantageous for people - 20 - having very light hair and light skin with little melanin in either the hair shaft or follicle, melanin being the chromophore normally used in other radiation hair removal techniques.
Another mechanism by which the teachings of this invention could be used for hair removal stems from the fact that papilla or bulb 23 is located in the upper regions of subcutaneous fat 16. Therefore, heating subcutaneous fat in the region of a hair follicle in the manner previously discussed will also result in a heating of the bulb/papilla of the hair follicle which can damage or destroy these structures. Damage or destruction of the bulb or papilla is another mechanism by which hair removal is effected.
The teachings of this invention may also be utilized to target lipid-rich tissue in other regions for other purposes. For example, the stratum corneum contains a layer of lipid tissue which serves as liquid barrier in a persons epidermis. This liquid barrier can reduce the effectiveness of needless injections which rely primarily on pressure to inject a liquid agent into the patient. A short burst of radiation at one of the wavelengths indicated above, for example 1715 nm or 2300 nm, could remove this lipid barrier in the area where the injection is to be made just prior to the injection to enhance the effectiveness thereof.
It is also known that the membranes walls of many cells are composed substantially of lipid and that these membranes differ somewhat from cell to cell. Radiation at one of the wavelengths indicated above may therefore be effective to selectively porate cells, the selectivity being achieved either as a result of controlling the focusing of the radiation to a targeted region and/or certain of the cells in the region porating at lower fluence or less time of radiation application than others as a result of cell size, wall thickness and/or other factors. Poration may be done for example to permit a drug or other therapeutic agent to enter the cell for healing or destruction thereof, for example, for the destruction of cancer cells, or to permit the content of the cell to flow out for various purposes. The poration may be temporary, or may be permanent resulting in cell destruction.
Finally, while in the discussion above the targeting of lipid as a chromophore for affecting hair removal in two different ways has been discussed, it is apparent that lipid could be targeted in other areas as a chromophore for the heating and either the destruction or therapy on other body components. Thus, in certain areas of the body, heating of lipid may be used to shrink collagen for wrinkle removal or skin toning or the lipid layer in the stratum corneum may be targeted for other purposes. Fat surrounding nerves, blood vessels or other biological structures may also be target for heating and treating the underlying structure. The radiation - 21 - wavelength, intensity, and pulse duration would in each instance be adjusted based on the size of the lipid structure being targeted, its depth, the wavelength utilized, and other factors.
Fig. 3 illustrates a technique which may be employed to treat subcutaneous fat either in areas where the dermis is too thick for treatment to be performed from the skin surface as shown in Fig. 2, where treatment is desired at depths in subcutaneous fat layer 16 which are too deep for treatment from the skin surface, where it is desired to operate at one of the more efficient longer wavelengths which do not normally penetrate to the subcutaneous fat, or for other reasons. In Fig. 3, a probe 40 is inserted through epidermis 12 and dermis 14 into subcutaneous fat region 16. Probe 40 may be a needle, or an opening may be formed in the skin through which a trocar or other cannula may be inserted, the probe 40 then passing through the cannula or trocar to the desired location. Other techniques known in the art for positioning a probe in subcutaneous fat region may be employed.
Probe 40 can contain an optical fiber or fiber bundle through which optical radiation at the wavelengths previously indicated may be applied to the end of the probe. The end of the probe may be formed to either direct the light straight ahead, to direct the light at some angle to the direction of the probe or to direct the radiation in more than one direction. Particularly where one of the longer wavelengths, for example 2300 nm, are utilized which have a high coefficient of absorption in fat, a dispersive lens might also be employed at the end of the needle to expend treatment area. A relatively large area of subcutaneous fat may be treated by a single insertion of the probe by moving the probe in and out of the subcutaneous fat and possibly by also rotating the probe about the entry point. Where light is coming out at an angle to the direction of the probe, the probe may also be rotated to cover a larger area. By inserting the probe at an angle as shown in Fig. 3, a larger area can be covered, though at a shallower depth. A smaller area to a greater depth can be covered by inserting probe 40 at a sharper angle. If the temperature to which the fat is raised by the radiations from the needle results in a liquid lipid pool being formed, a cannula could be included around the optical fiber in probe 40 to remove this liquid on a periodic or continuous basis, or the pool could be removed in the manner previously discussed. While the procedure of Fig. 3 may be used for any part of the body where fat is to be removed, it may be particularly advantageous for areas with smaller pockets of fat such as the face or neck. Further, while several techniques have been taught above for applying radiation within a preferentially absorbed wavelength band to subcutaneous - 22 - fat for the treatment thereof, other techniques, including various surgical techniques, could be utilized for reaching selected regions of subcutaneous fat in appropriate situations.
Another area where the teachings of this invention might be advantageously employed is to remove fat covering vessels, organs, or other anatomical elements on which a surgical procedure is to be performed so that the surgical procedure may be more accurately and safely performed with better visibility. In this instance, the tool for removing the fat might be inserted through a surgical opening or might be part of an endoscope or other tool inserted through a body cavity. The tool inserted could be similar to probe 40 and, to minimize damage to surrounding tissue, is preferably placed in contact with the fat to be treated, or at least in near contact with such fat, for irradiation. Thus, in Fig. 4 the tool is shown as a probe 50 inserted through a catheter 52 to the fat 54 surrounding a vessel, gut or other vital structure 56 to be surgically treated. Catheter 52 could also include a standard probe to permit viewing of the area under treatment so that catheter 52 can be repositioned and treatment can be continued until a sufficient amount of the fat 54 has been removed to expose vessel 56. Where larger surgical incisions are made, the tool for removal/treatment of fat 54 from vessel 56 might be hand held by the surgeon and manipulated by him to remove fat. Since fat 54 preferentially absorbs radiation at the applied wavelengths, and strongly absorbs at the higher wavelengths usable where there is substantial contract between the probe and the fat to be treated, the treatment of fat 54 should result in little if any thermal damage to underlying vessel 56 and, particularly if the wavelength is at approximately 1715 nm, or 2300 nm, this danger will be significantly reduced from prior art procedures were the radiation utilized was not preferentially absorbed by the fat tissue. More specifically, the fluence and exposure duration can be adjusted to ablate or otherwise treat fat, but not the nearby or underlying non-fat tissue.
A technique has thus been disclosed for the targeting of lipid-rich or fat tissue to effect a desired treatment by the selective application of optical radiation to such fat tissue at a wavelength preferentially absorbed thereby. While for various embodiments, the fat tissue for targeting has been discussed above, including the sebaceous gland, subcutaneous fat and fat surrounding anatomical elements on which surgical procedures are to be performed, the invention is not limited to targeting only such fat tissue, but may be employed for the targeting of any lipid-rich tissue. Further, while specific hardware has been described for producing radiation within the selected wavelength bands, other radiation sources capable of producing radiation within such bands might also be utilized. Finally, while specific methods and - 23 - hardware have been disclosed for applying the radiation to the various areas of lipid-rich tissue to be targeted, other techniques suitable for directing sufficient radiation at the requisite wavelengths to lipid-rich tissue may also be employed. Thus, while the invention has particularly been shown and described above with reference to preferred embodiments, the foregoing and other changes in form and detail may be made therein by those skilled in the art without departing from the spirit and scope of the invention, which invention is to be limited only by the following claims.

Claims

Claims
1. A method for selectively targeting lipid-rich tissue to effect a desired treatment, said method comprising irradiating said lipid-rich tissue with optical radiation at a wavelength for which absoφtion coefficients for fat and water have a ratio which is at least 0.5, the radiation being at a fluence and for a duration sufficient for the desired treatment.
2. A method as in claim 1 wherein said ratio is at least 1.
3. A method as in claim 1 wherein said wavelength is in a band which is one of (a) 880 to 935 nm, (b) 1150 to 1230 nm, (c) 1690 to 1780 nm, and (d) 2250 nm to 2450 nm.
4. A method as claimed in claim 3 wherein the wavelength is in a band which is one of 900 nm to 930 nm, 1190 to 1220 nm, 1700 nm to 1730 nm, and 2280 nm to 2360 nm.
5. A method as claimed in claim 4 wherein said wavelength is one of approximately 920 nm, 1210 nm, 1715 nm, 2300 nm and 3375 nm.
6. A method as claimed in claim 3 wherein said fluence varies as a function of a number of factors including the wavelength band utilized and the size of the lipid-rich tissue being treated.
7. A method as claimed in claim 3 wherein said fluence is approximately 0.5 J/cm2 to 500 J/cm2.
8. A method as claimed in claim 3 wherein said duration is approximately 4 fs to several minutes.
9. A method as claimed in claim 3 wherein the lipid-rich tissue is at least one sebaceous gland.
10. A method as claimed in claim 9 wherein irradiating said tissue is performed by applying said energy to the skin surface overlying the at least one sebaceous gland. -25-
11. A method as claimed in claim 10 wherein the wavelength is in one of band (b), (c), and (d).
12. A method as claimed in claim 3 wherein said lipid-rich tissue is subcutaneous fat.
13. A method as claimed in claim 12 wherein irradiating said tissue is performed by applying said energy to the skin surface overlying the subcutaneous fat to be treated.
14. A method as claimed in claim 13 wherein the wavelength is in one of band (a) and band (b).
15. A method as claimed in claim 13 wherein said energy is applied through an applicator applying pressure to skin above said subcutaneous fat to be treated.
16. A method as claimed in claim 13 including cooling the skin above the subcutaneous fat to be treated to a selected depth.
17. A method as claimed in claim 16 wherein said selected depth is in the dermal layer of said skin.
18. A method as claimed in claim 13 wherein a fold of skin containing subcutaneous fat to be treated is drawn into a slotted head and irradiated from at least two sides.
19. A method as claimed in claim 12 wherein irradiating said tissue is performed by applying said energy through a probe passed through the skin to the region of subcutaneous fat to be treated.
20. A method as claimed in claim 19 wherein said probe is passed into the subcutaneous fat at an angle to the skin surface, and including performing at least one of moving the probe in and out of the skin and rotating the probe about its skin entry point to irradiate and treat subcutaneous fat over a selected area.
21. A method as claimed in claim 19 including removing liquid fat formed as a result of the irradiation ablating lipid tissue walls through a cannula included as part of said probe. - 26 -
22. A method as claimed in claim 12 wherein the radiation applied to said subcutaneous fat tissue is of sufficient fluence and duration to ablate walls of such tissue to form a liquid fat pool.
23. A method as claimed in claim 22 including inserting a needle into said pool, and removing liquid fat from said pool through said needle.
24. A method as claimed in claim 22 including said pool being absorbed into a patient's body.
25. A method as claimed in claim 22 including draining said pool through an opening in the patient's skin.
26. A method as claimed in claim 3 including focusing radiation to a treatment area in the subcutaneous fat.
27. A method as claimed in claim 22 wherein said fluence and duration are such that ablations of tissue walls occurs only to a selected depth in said subcutaneous layer.
28. A method as claimed in claim 3 wherein said lipid-rich tissue is fat surrounding an anatomical element on which a surgical procedure is to be performed, and wherein irradiating said tissue is performed by a tool in at least near contact with the fat to remove the fat from and thereby expose the element.
29. A method as claimed in claim 27 wherein said wavelength is in one of bands (b), (c), and (d).
30. A method as claimed in claim 3 wherein said treatment is achieved photomechanically, and wherein said duration is less than 1 μs.
31. A method as claimed in claim 3 wherein said lipid-rich tissue is heated to heat and treat tissue adjacent thereto. - 27 -
32. A method as claimed in claim 31 wherein said lipid-rich tissue a sebaceous gland, heating of the sebaceous gland effecting hair removal.
33. A method as claimed in claim 32 wherein said lipid-rich tissue a subcutaneous fat, heating of the subcutaneous fat effecting hair removal.
34. A method as claimed in claim 3 wherein said lipid-rich tissues a cell membrane, heating of the cell membrane selectively porating the cell.
35. Apparatus for selectively targeting lipid-rich tissue to effect a desired treatement, said apparatus including: a source of radiation at a wavelength for which absoφtion coefficients for fat and water have a ratio which is at least 0.5, said source when energized, providing the radiation at a fluence and for a duration sufficient for the desired treatment; and a component which delivers the energy from said source to the lipid-rich tissue to be treated.
36. Apparatus as claimed in claim 35 wherein said ratio is at least 1.
37. Apparatus as claimed in claim 35 wherein said wavelength is in a band which is one of (a) 880 to 935 nm, (b) 1160 to 1230 nm, (c) 1690 to 1780 nm, and (d) 2250 nm to 2450 nm.
38. Apparatus as claimed in claim 37 wherein the wavelength is in a band which is one of 900 nm to 930 nm, 1190 to 1220 nm, 1700 nm to 1730 nm, and 2280 nm to 2350 nm.
39. Apparatus as claimed in claim 37 wherein said fluence is approximately 0.5 J/cm2 to 500 J/cm.
40. Apparatus as claimed in claim 37 wherein said source is a potassium cadmium laser with a matrix KCd(WO4)2 which is doped with Er3+ ions, with an orientation such that the axis of the laser beam is at an angle greater than 45 degrees with the crystalline axis [010], the source generating an output at approximately 1715 nm. - 28 -
41. Apparatus as claimed in claim 37 wherein the component is an applicator adapted to be in pressure contact with skin above the lipid-rich tissue to be treated.
42. Apparatus as claimed in claim 37 wherein said energy is applied to the lipid-rich tissue to be treated through overlying skin, and wherein the component includes a mechanism which cools said overlying skin to a selected depth.
43. Apparatus as claimed in claim 37 wherein said component is a probe applied through skin overlying the lipid-rich tissue to be treated to a region containing such tissue.
44. Apparatus as claimed in claim 43 wherein said probe includes a cannula through which liquid fat formed as a result of the irradiation ablating lipid tissue walls is removed.
45. Apparatus as claimed in claim 37 including a cannula inserted into a pool of liquid fat formed as a result of the irradiation melting lipid tissue walls to remove the liquid fat.
46. Apparatus as claimed in claim 37 including a slotted head for irradiation delivery, and a mechanism for drawing a fold of skin to undergo said desired treatement into said slot of said head. 48. Apparatus as claimed in claim 37 wherein said component is a tool which is adapted to be brought into at least near contact with lipid-rich tissue surrounding an anatomical element on which a surgical procedure is to be performed.
49. Apparatus as claimed in claim 37 wherein said fluence is approximately 0.5 J/cm2 to 500 J/cm2, depending on a number of factors including wavelength band utilized and size of the lipid-rich tissue being treated.
50. Apparatus as claimed in claim 37 wherein said duration is approximately 4 fs to several minutes.
PCT/US1999/006475 1998-03-27 1999-03-26 Method and apparatus for the selective targeting of lipid-rich tissues WO1999049937A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES99915023T ES2403359T3 (en) 1998-03-27 1999-03-26 Procedure and apparatus for the selective determination of lipid rich tissues
AU33639/99A AU3363999A (en) 1998-03-27 1999-03-26 Method and apparatus for the selective targeting of lipid-rich tissues
EP99915023A EP1066086B1 (en) 1998-03-27 1999-03-26 Method and apparatus for the selective targeting of lipid-rich tissues
CA2326120A CA2326120C (en) 1998-03-27 1999-03-26 Method and apparatus for the selective targeting of lipid-rich tissues

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7971098P 1998-03-27 1998-03-27
US60/079,710 1998-03-27

Publications (1)

Publication Number Publication Date
WO1999049937A1 true WO1999049937A1 (en) 1999-10-07

Family

ID=22152299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/006475 WO1999049937A1 (en) 1998-03-27 1999-03-26 Method and apparatus for the selective targeting of lipid-rich tissues

Country Status (6)

Country Link
US (3) US6605080B1 (en)
EP (2) EP1066086B1 (en)
AU (1) AU3363999A (en)
CA (1) CA2326120C (en)
ES (2) ES2403359T3 (en)
WO (1) WO1999049937A1 (en)

Cited By (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1294444A2 (en) * 2000-04-03 2003-03-26 CeramOptec GmbH Therapeutic laser system operating between 1000 and 1300 nm and its use
US6544255B2 (en) 1997-04-04 2003-04-08 Keralase Ltd. Method of hair removal by transcutaneous application of laser light
WO2004000150A1 (en) * 2002-06-19 2003-12-31 Palomar Medical Technologies, Inc. Method and apparatus for photothermal treatment of tissue at depth
US6723090B2 (en) 2001-07-02 2004-04-20 Palomar Medical Technologies, Inc. Fiber laser device for medical/cosmetic procedures
WO2004041104A1 (en) * 2002-11-04 2004-05-21 Universita' Degli Studi Di Padova Laser apparatus for treating hard tissues and method for using the apparatus
US6743222B2 (en) 1999-12-10 2004-06-01 Candela Corporation Method of treating disorders associated with sebaceous follicles
WO2004073537A2 (en) * 2003-02-19 2004-09-02 Palomar Medical Technologies, Inc. Method and apparatus for treating pseudofolliculitis barbae
WO2007118246A1 (en) * 2006-04-07 2007-10-18 The General Hospital Corporation Method, system and apparatus for dermatological treatment and fractusal skin resurfacing
WO2008008971A1 (en) * 2006-07-13 2008-01-17 Candela Corporation Compact, handheld device for home-based acne treatment
US7384797B1 (en) 2000-10-12 2008-06-10 University Of Utah Research Foundation Resonant optical cavities for high-sensitivity high-throughput biological sensors and methods
US20080215040A1 (en) * 2007-03-02 2008-09-04 Paithankar Dilip Y Variable depth skin heating with lasers
US7470270B2 (en) 2001-06-27 2008-12-30 Radiancy Inc. Acne treatment
EP2260801A2 (en) 2002-03-15 2010-12-15 The General Hospital Corporation Method for selective disruption of fatty tissue by controlled cooling
US20110040295A1 (en) * 2003-02-28 2011-02-17 Photometics, Inc. Cancer treatment using selective photo-apoptosis
US8790381B2 (en) 2003-02-28 2014-07-29 Photometics, Inc. Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US9314368B2 (en) 2010-01-25 2016-04-19 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods
US9408745B2 (en) 2007-08-21 2016-08-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
US9486285B2 (en) 2006-06-14 2016-11-08 Candela Corporation Treatment of skin by spatial modulation of thermal heating
US9518288B2 (en) 2008-04-11 2016-12-13 University Of Utah Research Foundation Methods and compositions related to quantitative, array based methylation analysis
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US9655770B2 (en) 2007-07-13 2017-05-23 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US9737434B2 (en) 2008-12-17 2017-08-22 Zeltiq Aestehtics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9861421B2 (en) 2014-01-31 2018-01-09 Zeltiq Aesthetics, Inc. Compositions, treatment systems and methods for improved cooling of lipid-rich tissue
US9861520B2 (en) 2009-04-30 2018-01-09 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10092346B2 (en) 2010-07-20 2018-10-09 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10292859B2 (en) 2006-09-26 2019-05-21 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US10383787B2 (en) 2007-05-18 2019-08-20 Zeltiq Aesthetics, Inc. Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US10524956B2 (en) 2016-01-07 2020-01-07 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10722395B2 (en) 2011-01-25 2020-07-28 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US10864380B1 (en) 2020-02-29 2020-12-15 Cutera, Inc. Systems and methods for controlling therapeutic laser pulse duration
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
US11154418B2 (en) 2015-10-19 2021-10-26 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
US11253720B2 (en) 2020-02-29 2022-02-22 Cutera, Inc. Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US11395760B2 (en) 2006-09-26 2022-07-26 Zeltiq Aesthetics, Inc. Tissue treatment methods
US11400308B2 (en) 2017-11-21 2022-08-02 Cutera, Inc. Dermatological picosecond laser treatment systems and methods using optical parametric oscillator
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11446175B2 (en) 2018-07-31 2022-09-20 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
US11590020B2 (en) 2002-03-15 2023-02-28 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling

Families Citing this family (268)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141049B2 (en) * 1999-03-09 2006-11-28 Thermage, Inc. Handpiece for treatment of tissue
US7189230B2 (en) * 1996-01-05 2007-03-13 Thermage, Inc. Method for treating skin and underlying tissue
US7452358B2 (en) * 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US7229436B2 (en) * 1996-01-05 2007-06-12 Thermage, Inc. Method and kit for treatment of tissue
US7473251B2 (en) * 1996-01-05 2009-01-06 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US7115123B2 (en) * 1996-01-05 2006-10-03 Thermage, Inc. Handpiece with electrode and non-volatile memory
US20030212393A1 (en) * 1996-01-05 2003-11-13 Knowlton Edward W. Handpiece with RF electrode and non-volatile memory
US6599316B2 (en) * 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US20060149343A1 (en) * 1996-12-02 2006-07-06 Palomar Medical Technologies, Inc. Cooling system for a photocosmetic device
US8182473B2 (en) 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
JP4056091B2 (en) 1997-05-15 2008-03-05 パロマー・メディカル・テクノロジーズ・インコーポレーテッド Dermatological treatment method and apparatus
US6104959A (en) 1997-07-31 2000-08-15 Microwave Medical Corp. Method and apparatus for treating subcutaneous histological features
US6267761B1 (en) * 1997-09-09 2001-07-31 Sherwood Services Ag Apparatus and method for sealing and cutting tissue
GB9721506D0 (en) * 1997-10-10 1997-12-10 Virulite Limited Treatment of diseases
WO1999046005A1 (en) 1998-03-12 1999-09-16 Palomar Medical Technologies, Inc. System for electromagnetic radiation of the skin
AU3363999A (en) * 1998-03-27 1999-10-18 General Hospital Corporation, The Method and apparatus for the selective targeting of lipid-rich tissues
US6059820A (en) 1998-10-16 2000-05-09 Paradigm Medical Corporation Tissue cooling rod for laser surgery
US6514242B1 (en) * 1998-12-03 2003-02-04 David Vasily Method and apparatus for laser removal of hair
US20020156471A1 (en) * 1999-03-09 2002-10-24 Stern Roger A. Method for treatment of tissue
US7041094B2 (en) * 1999-03-15 2006-05-09 Cutera, Inc. Tissue treatment device and method
US20030036749A1 (en) * 1999-12-10 2003-02-20 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles
EP1261307A1 (en) 1999-12-15 2002-12-04 Tensor Technologies, LLC Massage device
IL150604A0 (en) * 2000-01-25 2003-02-12 Palomar Medical Tech Inc Method and apparatus for medical treatment utilizing long duration electromagnetic radiation
US6921413B2 (en) * 2000-08-16 2005-07-26 Vanderbilt University Methods and devices for optical stimulation of neural tissues
US20060004347A1 (en) * 2000-12-28 2006-01-05 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
CA2433022C (en) * 2000-12-28 2016-12-06 Palomar Medical Technologies, Inc. Method and apparatus for therapeutic emr treatment of the skin
US20080214988A1 (en) * 2000-12-28 2008-09-04 Palomar Medical Technologies, Inc. Methods And Devices For Fractional Ablation Of Tissue
US7347855B2 (en) * 2001-10-29 2008-03-25 Ultrashape Ltd. Non-invasive ultrasonic body contouring
US7285091B2 (en) * 2001-01-11 2007-10-23 The Johns Hopkins University Assessment of tooth structure using laser based ultrasonics
US6888319B2 (en) * 2001-03-01 2005-05-03 Palomar Medical Technologies, Inc. Flashlamp drive circuit
EP1365699A2 (en) * 2001-03-02 2003-12-03 Palomar Medical Technologies, Inc. Apparatus and method for photocosmetic and photodermatological treatment
CA2445776C (en) 2001-05-03 2010-07-20 Advanced Light Technology, Llc Differential photochemical & photomechanical processing
US7329274B2 (en) * 2001-11-29 2008-02-12 Palomar Medical Technologies, Inc. Conforming oral phototherapy applicator
US20030109787A1 (en) * 2001-12-12 2003-06-12 Michael Black Multiple laser diagnostics
US20030109860A1 (en) * 2001-12-12 2003-06-12 Michael Black Multiple laser treatment
WO2003057059A1 (en) * 2001-12-27 2003-07-17 Palomar Medical Technologies, Inc. Method and apparatus for improved vascular related treatment
US20070239142A1 (en) * 2006-03-10 2007-10-11 Palomar Medical Technologies, Inc. Photocosmetic device
WO2003101529A2 (en) * 2002-05-31 2003-12-11 Duke University Office Of Science And Technology Method and apparatus for infrared tissue ablation
US7250047B2 (en) * 2002-08-16 2007-07-31 Lumenis Ltd. System and method for treating tissue
US20040156743A1 (en) * 2002-08-28 2004-08-12 Eric Bornstein Near infrared microbial elimination laser system
US20080131968A1 (en) * 2002-08-28 2008-06-05 Nomir Medical Technologies, Inc. Near-infrared electromagnetic modification of cellular steady-state membrane potentials
US20040126272A1 (en) * 2002-08-28 2004-07-01 Eric Bornstein Near infrared microbial elimination laser system
US7713294B2 (en) * 2002-08-28 2010-05-11 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser systems (NIMEL)
US8506979B2 (en) 2002-08-28 2013-08-13 Nomir Medical Technologies, Inc. Near-infrared electromagnetic modification of cellular steady-state membrane potentials
US7259906B1 (en) 2002-09-03 2007-08-21 Cheetah Omni, Llc System and method for voice control of medical devices
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US20070219604A1 (en) * 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue with radiant energy
EP2522293A2 (en) 2002-10-23 2012-11-14 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances
US7255560B2 (en) * 2002-12-02 2007-08-14 Nomir Medical Technologies, Inc. Laser augmented periodontal scaling instruments
WO2004058352A2 (en) * 2002-12-20 2004-07-15 Palomar Medical Technologies, Inc. Apparatus for light treatment of acne and other disorders of follicles
US7703458B2 (en) 2003-02-21 2010-04-27 Cutera, Inc. Methods and devices for non-ablative laser treatment of dermatologic conditions
ES2570987T3 (en) 2003-02-25 2016-05-23 Tria Beauty Inc Dermatological treatment device, based on diode laser and autonomous
EP2604215B1 (en) 2003-02-25 2017-10-11 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus and method
WO2004075731A2 (en) * 2003-02-25 2004-09-10 Spectragenics, Inc. Acne treatment device and method
US7250045B2 (en) * 2003-02-25 2007-07-31 Spectragenics, Inc. Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
US7452356B2 (en) * 2003-02-25 2008-11-18 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus
US7981111B2 (en) 2003-02-25 2011-07-19 Tria Beauty, Inc. Method and apparatus for the treatment of benign pigmented lesions
US7413567B2 (en) * 2003-02-25 2008-08-19 Spectragenics, Inc. Optical sensor and method for identifying the presence of skin
JP2004259144A (en) * 2003-02-27 2004-09-16 Renesas Technology Corp Semiconductor storage device
US20040176824A1 (en) * 2003-03-04 2004-09-09 Weckwerth Mark V. Method and apparatus for the repigmentation of human skin
WO2004080279A2 (en) * 2003-03-06 2004-09-23 Spectragenics, Inc. In the patent cooperation treaty application for patent
EP2277470B1 (en) 2003-03-27 2013-10-09 The General Hospital Corporation Apparatus for dermatological treatment and fractional skin resurfacing
US7470124B2 (en) * 2003-05-08 2008-12-30 Nomir Medical Technologies, Inc. Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
US8870856B2 (en) 2003-08-25 2014-10-28 Cutera, Inc. Method for heating skin using light to provide tissue treatment
US8915906B2 (en) 2003-08-25 2014-12-23 Cutera, Inc. Method for treatment of post-partum abdominal skin redundancy or laxity
US7722600B2 (en) 2003-08-25 2010-05-25 Cutera, Inc. System and method for heating skin using light to provide tissue treatment
JP2007508065A (en) * 2003-10-08 2007-04-05 エリック ボーンステイン, Use of secondary light emission as a novel biofilm targeting technology
US20080172045A1 (en) * 2003-10-24 2008-07-17 Shanks Steven C Acne treatment device
US7326199B2 (en) 2003-12-22 2008-02-05 Cutera, Inc. System and method for flexible architecture for dermatologic treatments utilizing multiple light sources
US7184184B2 (en) * 2003-12-31 2007-02-27 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
US7282060B2 (en) 2003-12-23 2007-10-16 Reliant Technologies, Inc. Method and apparatus for monitoring and controlling laser-induced tissue treatment
WO2005065565A1 (en) * 2003-12-31 2005-07-21 Palomar Medical Technologies, Inc. Dermatological treatment with vusualization
US7090670B2 (en) * 2003-12-31 2006-08-15 Reliant Technologies, Inc. Multi-spot laser surgical apparatus and method
US7196831B2 (en) * 2003-12-31 2007-03-27 Reliant Technologies, Inc. Two-dimensional optical scan system using a counter-rotating disk scanner
US7372606B2 (en) 2003-12-31 2008-05-13 Reliant Technologies, Inc. Optical pattern generator using a single rotating component
US20080125837A1 (en) * 2004-02-06 2008-05-29 Therapy Products, Inc. Noninvasive method for site-specific fat reduction with catalyst
US8777935B2 (en) 2004-02-25 2014-07-15 Tria Beauty, Inc. Optical sensor and method for identifying the presence of skin
JP5065005B2 (en) 2004-04-01 2012-10-31 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for dermatological treatment and tissue remodeling
US20050251117A1 (en) * 2004-05-07 2005-11-10 Anderson Robert S Apparatus and method for treating biological external tissue
US7842029B2 (en) 2004-05-07 2010-11-30 Aesthera Apparatus and method having a cooling material and reduced pressure to treat biological external tissue
US20070179482A1 (en) * 2004-05-07 2007-08-02 Anderson Robert S Apparatuses and methods to treat biological external tissue
US8571648B2 (en) * 2004-05-07 2013-10-29 Aesthera Apparatus and method to apply substances to tissue
US7413572B2 (en) 2004-06-14 2008-08-19 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
GB0414113D0 (en) * 2004-06-24 2004-07-28 Virulite Distrib Ltd Cosmetic uses of electromagnetic radiation
US20110160712A1 (en) * 2004-07-12 2011-06-30 Nikolai Tankovich Laser treatment system and method for producing thermal cavities and energy droplets
US7837675B2 (en) 2004-07-22 2010-11-23 Shaser, Inc. Method and device for skin treatment with replaceable photosensitive window
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
EP1879502A2 (en) 2004-10-06 2008-01-23 Guided Therapy Systems, L.L.C. Method and system for cosmetic enhancement
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US20150025420A1 (en) * 2004-10-06 2015-01-22 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
KR101605527B1 (en) 2004-10-06 2016-03-22 가이디드 테라피 시스템스, 엘.엘.씨. Ultrasound treatment system
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US10857722B2 (en) * 2004-12-03 2020-12-08 Pressco Ip Llc Method and system for laser-based, wavelength specific infrared irradiation treatment
US7425296B2 (en) * 2004-12-03 2008-09-16 Pressco Technology Inc. Method and system for wavelength specific thermal irradiation and treatment
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
BRPI0607903A2 (en) * 2005-02-18 2009-10-20 Palomar Medical Tech Inc dermatological treatment device
US20060253176A1 (en) * 2005-02-18 2006-11-09 Palomar Medical Technologies, Inc. Dermatological treatment device with deflector optic
WO2006093384A1 (en) * 2005-03-02 2006-09-08 Meridian Co., Ltd. Adipose resolve apparatus for low-power laser
US7975702B2 (en) * 2005-04-05 2011-07-12 El.En. S.P.A. System and method for laser lipolysis
US8801764B2 (en) * 2005-05-05 2014-08-12 Biolitec Pharma Marketing Ltd Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
US8276590B2 (en) * 2005-05-18 2012-10-02 Cooltouch Incorporated Thermally mediated tissue molding
US8357146B2 (en) * 2005-05-18 2013-01-22 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
US8256429B2 (en) * 2005-05-18 2012-09-04 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
US7217265B2 (en) * 2005-05-18 2007-05-15 Cooltouch Incorporated Treatment of cellulite with mid-infrared radiation
US8127771B2 (en) * 2005-05-18 2012-03-06 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
GB0512038D0 (en) * 2005-06-14 2005-07-20 Dougal Gordon Therapeutic and cosmetic uses of electromagnetic radiation
US20080114423A1 (en) 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
US20090043365A1 (en) 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US20070060988A1 (en) 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US20070016256A1 (en) 2005-07-18 2007-01-18 Korb Donald R Method and apparatus for treating gland dysfunction
US8255039B2 (en) * 2006-09-29 2012-08-28 Tearscience, Inc. Meibomian gland illuminating and imaging
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
WO2013003594A2 (en) * 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
AU2006272766A1 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (NIMELS)
US20070031482A1 (en) 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
US20070176262A1 (en) * 2005-08-11 2007-08-02 Ernest Sirkin Series connection of a diode laser bar
US8323273B2 (en) * 2005-08-12 2012-12-04 Board Of Regents, The University Of Texas System Systems, devices, and methods for optically clearing tissue
US20070173799A1 (en) * 2005-09-01 2007-07-26 Hsia James C Treatment of fatty tissue adjacent an eye
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US7967763B2 (en) 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
AU2006292526A1 (en) 2005-09-15 2007-03-29 Palomar Medical Technologies, Inc. Skin optical characterization device
WO2007038567A1 (en) 2005-09-28 2007-04-05 Candela Corporation Treating cellulite
JP2007089992A (en) * 2005-09-30 2007-04-12 Terumo Corp Energy irradiation device, control device and control method
US20070083190A1 (en) * 2005-10-11 2007-04-12 Yacov Domankevitz Compression device for a laser handpiece
US7519253B2 (en) 2005-11-18 2009-04-14 Omni Sciences, Inc. Broadband or mid-infrared fiber light sources
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US8540703B2 (en) 2005-12-23 2013-09-24 Lutronic Corporation Methods for treating skin conditions using laser
US7891362B2 (en) 2005-12-23 2011-02-22 Candela Corporation Methods for treating pigmentary and vascular abnormalities in a dermal region
WO2007073024A2 (en) 2005-12-23 2007-06-28 Max Engineering Ltd. Method of curing inflammatory acne by using carbon lotion and pulsed laser
US20070154538A1 (en) * 2005-12-29 2007-07-05 Ceramoptec Gmbh Removal of fat cells by PDT
EP1973510B1 (en) * 2006-01-20 2010-09-22 Eleme Medical Inc. Mechanical massage device
CA2642741A1 (en) * 2006-01-24 2007-08-02 Nomir Medical Technologies, Inc. Optical method and device for modulation of biochemical processes in adipose tissue
US20070194717A1 (en) * 2006-02-17 2007-08-23 Palomar Medical Technologies, Inc. Lamp for use in a tissue treatment device
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
KR100742973B1 (en) * 2006-02-22 2007-07-27 주식회사 루트로닉 Fatty tissue removing using 1444nm beam oscillating nd:yag laser
KR100799524B1 (en) * 2006-02-28 2008-01-31 전용규 An applicator in a device for treating skin
WO2007103721A2 (en) * 2006-03-01 2007-09-13 The General Hospital Corporation System and method for providing cell specific laser therapy of atherosclerotic plaques by targeting light absorbers in macrophages
US7814915B2 (en) * 2006-03-03 2010-10-19 Cutera, Inc. Aesthetic treatment for wrinkle reduction and rejuvenation
US20090048514A1 (en) * 2006-03-09 2009-02-19 Slender Medical Ltd. Device for ultrasound monitored tissue treatment
KR100649890B1 (en) * 2006-03-27 2006-11-28 주식회사 루트로닉 Control method and control structure of laser beam irradiation by using a contact sensor
WO2007117580A2 (en) * 2006-04-06 2007-10-18 Palomar Medical Technologies, Inc. Apparatus and method for skin treatment with compression and decompression
WO2007118244A1 (en) * 2006-04-07 2007-10-18 The General Hospital Corporation Method and apparatus for producing thermal damage within the skin
US9078680B2 (en) * 2006-04-12 2015-07-14 Lumenis Ltd. System and method for microablation of tissue
WO2007126999A2 (en) 2006-04-12 2007-11-08 Lumenis Ltd. System and method for microablation of tissue
US20130274834A1 (en) * 2006-04-18 2013-10-17 Daniel Barolet Method for the treatment of skin tissues.
WO2007134257A2 (en) * 2006-05-11 2007-11-22 Reliant Technologies, Inc. Apparatus and method for a combination of ablative and nonablative dermatological treatment
US20070264625A1 (en) * 2006-05-11 2007-11-15 Reliant Technologies, Inc. Apparatus and Method for Ablation-Related Dermatological Treatment of Selected Targets
US20080161745A1 (en) * 2006-09-08 2008-07-03 Oliver Stumpp Bleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system
US20080082091A1 (en) * 2006-09-10 2008-04-03 Vladimir Rubtsov Fiber optic tissue ablation
US8249695B2 (en) * 2006-09-29 2012-08-21 Tearscience, Inc. Meibomian gland imaging
EP2089107A2 (en) * 2006-12-12 2009-08-19 Nomir Medical Technologies, Inc Near-infrared electromagnetic modification of cellular steady- state membrane potentials
US20080154247A1 (en) * 2006-12-20 2008-06-26 Reliant Technologies, Inc. Apparatus and method for hair removal and follicle devitalization
US20080221649A1 (en) * 2007-03-09 2008-09-11 Agustina Echague Method of sequentially treating tissue
EP2139560B1 (en) * 2007-03-19 2012-05-30 Syneron Medical Ltd. Device for soft tissue destruction
US20100211059A1 (en) 2007-04-19 2010-08-19 Deem Mark E Systems and methods for creating an effect using microwave energy to specified tissue
US9241763B2 (en) 2007-04-19 2016-01-26 Miramar Labs, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
JP2010524589A (en) 2007-04-19 2010-07-22 ザ ファウンドリー, インコーポレイテッド Method, apparatus and system for non-invasive delivery of microwave therapy
US9149331B2 (en) 2007-04-19 2015-10-06 Miramar Labs, Inc. Methods and apparatus for reducing sweat production
CN101711134B (en) 2007-04-19 2016-08-17 米勒玛尔实验室公司 Tissue is applied the system of microwave energy and in organized layer, produces the system of tissue effect
US20080262484A1 (en) * 2007-04-23 2008-10-23 Nlight Photonics Corporation Motion-controlled laser surface treatment apparatus
US20080269735A1 (en) * 2007-04-26 2008-10-30 Agustina Vila Echague Optical array for treating biological tissue
US20090012434A1 (en) * 2007-07-03 2009-01-08 Anderson Robert S Apparatus, method, and system to treat a volume of skin
US8236036B1 (en) 2007-07-21 2012-08-07 Frost Ricky A Optical dermatological and medical treatment apparatus having replaceable laser diodes
EP2194899A4 (en) 2007-08-08 2012-11-28 Tria Beauty Inc Capacitive sensing method and device for detecting skin
US20090069795A1 (en) * 2007-09-10 2009-03-12 Anderson Robert S Apparatus and method for selective treatment of tissue
CA2604112C (en) * 2007-09-24 2016-07-05 Meridian Co. Ltd. Adipose resolve apparatus for low-power laser
WO2009045885A2 (en) * 2007-10-02 2009-04-09 Board Of Regents, The University Of Texas System Real-time ultrasound monitoring of heat-induced tissue interactions
US20090093864A1 (en) * 2007-10-08 2009-04-09 Anderson Robert S Methods and devices for applying energy to tissue
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
EP2248392B1 (en) * 2007-10-22 2013-01-16 Radiancy Inc. Hand held skin treatment device
WO2009064750A1 (en) * 2007-11-12 2009-05-22 Microaire Surgical Instruments Surgical liposuction instrument with radiant energy source
ES2471971T3 (en) 2007-12-12 2014-06-27 Miramar Labs, Inc. System and apparatus for non-invasive treatment of tissue using microwave energy
AU2008335715B2 (en) 2007-12-12 2014-01-23 Miradry, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US20090254155A1 (en) * 2008-04-04 2009-10-08 Medical Quant Usa, Inc. Dba Multi Radiance Medical Therapeutic emitter retaining device
JP5628792B2 (en) 2008-04-25 2014-11-19 トリア ビューティ インコーポレイテッド Optical sensor and method for distinguishing skin presence and skin pigmentation
EP2306919B1 (en) * 2008-05-02 2012-03-21 Curve Medical Llc Laser energy devices for soft tissue removal
KR100987386B1 (en) * 2008-05-15 2010-10-12 한국전자통신연구원 Multi-resonant fiber laser system
KR102147455B1 (en) 2008-06-06 2020-08-24 얼테라, 인크 Ultrasound treatment system
GB0812753D0 (en) * 2008-07-14 2008-08-20 Dougal Gordon R P Electromagnetic radiation and its therapeutic effect
WO2010027829A2 (en) * 2008-08-25 2010-03-11 Laser Abrasive Technologies, Llc Method and apparatus for regeneration of oral cavity tissues
WO2010036732A1 (en) 2008-09-25 2010-04-01 Zeltiq Aesthetics, Inc. Treatment planning systems and methods for body contouring applications
US8357150B2 (en) 2009-07-20 2013-01-22 Syneron Medical Ltd. Method and apparatus for fractional skin treatment
US8167280B2 (en) * 2009-03-23 2012-05-01 Cabochon Aesthetics, Inc. Bubble generator having disposable bubble cartridges
EP2413699B1 (en) 2009-04-01 2019-11-20 Tearscience, Inc. Ocular surface interferometry (osi) apparatus for imaging an ocular tear film
WO2010142013A1 (en) * 2009-06-08 2010-12-16 Biolux Research Limited Method and device for accelerating orthodontic tooth movement
KR101049160B1 (en) 2009-07-06 2011-07-14 주식회사 루트로닉 Νd : BAA laser device
US8465471B2 (en) 2009-08-05 2013-06-18 Rocin Laboratories, Inc. Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient
US8348929B2 (en) 2009-08-05 2013-01-08 Rocin Laboratories, Inc. Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US8591555B2 (en) * 2009-08-31 2013-11-26 Warsaw Orthopedic, Inc. System with integral locking mechanism
US20110190745A1 (en) * 2009-12-04 2011-08-04 Uebelhoer Nathan S Treatment of sweat glands
KR100963395B1 (en) * 2009-12-16 2010-06-14 단국대학교 산학협력단 Method and apparatus for elliminating fat using infrared optical parametric oscillator laser
WO2011084863A2 (en) 2010-01-07 2011-07-14 Cheetah Omni, Llc Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy
US9038640B2 (en) 2011-03-31 2015-05-26 Viora Ltd. System and method for fractional treatment of skin
US9314301B2 (en) 2011-08-01 2016-04-19 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device
KR101322658B1 (en) * 2011-11-24 2013-10-30 주식회사 루트로닉 Apparatus for treating medical using laser
US9522289B2 (en) 2012-05-08 2016-12-20 The Regents Of The University Of California Selective fat removal using photothermal heating
JP2015515915A (en) * 2012-05-08 2015-06-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Fine space-time control of thermolysis and repolisis using NIR light
US9480529B2 (en) * 2012-06-22 2016-11-01 S & Y Enterprises Llc Aesthetic treatment device and method
DE102012013534B3 (en) 2012-07-05 2013-09-19 Tobias Sokolowski Apparatus for repetitive nerve stimulation for the degradation of adipose tissue by means of inductive magnetic fields
US9993658B2 (en) 2012-08-16 2018-06-12 Yolo Medical Inc. Light applicators, systems and methods
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US20140125532A1 (en) * 2012-11-08 2014-05-08 University Of Utah Tattooed antennas
WO2014105521A1 (en) 2012-12-31 2014-07-03 Omni Medsci, Inc. Short-wave infrared super-continuum lasers for early detection of dental caries
US10589120B1 (en) 2012-12-31 2020-03-17 Gary John Bellinger High-intensity laser therapy method and apparatus
EP2938259A4 (en) 2012-12-31 2016-08-17 Omni Medsci Inc Near-infrared lasers for non-invasive monitoring of glucose, ketones, hba1c, and other blood constituents
US9993159B2 (en) 2012-12-31 2018-06-12 Omni Medsci, Inc. Near-infrared super-continuum lasers for early detection of breast and other cancers
US10660526B2 (en) 2012-12-31 2020-05-26 Omni Medsci, Inc. Near-infrared time-of-flight imaging using laser diodes with Bragg reflectors
WO2014143276A2 (en) 2012-12-31 2014-09-18 Omni Medsci, Inc. Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications
US9164032B2 (en) 2012-12-31 2015-10-20 Omni Medsci, Inc. Short-wave infrared super-continuum lasers for detecting counterfeit or illicit drugs and pharmaceutical process control
CN104027893B (en) 2013-03-08 2021-08-31 奥赛拉公司 Apparatus and method for multi-focal ultrasound therapy
EP2968925B1 (en) 2013-03-14 2020-02-19 Cynosure, LLC Electrosurgical systems
EP2967711B1 (en) 2013-03-15 2020-05-06 Cynosure, LLC Electrosurgical instruments with multimodes of operation
CA2911294C (en) 2013-05-03 2022-08-30 Tearscience, Inc. Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis
WO2015013502A2 (en) 2013-07-24 2015-01-29 Miramar Labs, Inc. Apparatus and methods for the treatment of tissue using microwave energy
US9655926B1 (en) * 2013-08-23 2017-05-23 Amiya Prasad Treatment for hair thinning and hair loss
CN105682603A (en) 2013-10-22 2016-06-15 碧奥鲁克斯研究有限公司 Intra-oral light-therapy apparatuses and methods for their use
EP3131630B1 (en) 2014-04-18 2023-11-29 Ulthera, Inc. Band transducer ultrasound therapy
KR20150125267A (en) * 2014-04-30 2015-11-09 (주)아모레퍼시픽 Kit for lipolysis by radiating light
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US10821295B1 (en) 2015-07-01 2020-11-03 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10478634B2 (en) 2015-07-01 2019-11-19 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US20180001107A1 (en) 2016-07-01 2018-01-04 Btl Holdings Limited Aesthetic method of biological structure treatment by magnetic field
US10569095B1 (en) 2015-07-01 2020-02-25 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10695576B2 (en) 2015-07-01 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US10569094B2 (en) 2015-07-01 2020-02-25 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US9937358B2 (en) 2015-07-01 2018-04-10 Btl Holdings Limited Aesthetic methods of biological structure treatment by magnetic field
US10709894B2 (en) 2015-07-01 2020-07-14 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US20170050048A1 (en) * 2015-08-10 2017-02-23 Oren Aharon Method or apparatus for wrinkle treatment
US10080906B2 (en) * 2015-09-30 2018-09-25 Btl Holdings Limited Methods and devices for tissue treatment using mechanical stimulation and electromagnetic field
US11484724B2 (en) 2015-09-30 2022-11-01 Btl Medical Solutions A.S. Methods and devices for tissue treatment using mechanical stimulation and electromagnetic field
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US10667862B2 (en) 2015-11-20 2020-06-02 Boston Scientific Scimed, Inc. Laser-based surgical systems and related methods
ITUB20159634A1 (en) * 2015-12-22 2017-06-22 Quanta System Spa LASER DEVICE FOR SELECTIVE TREATMENT OF ACNE WITH REDUCED INCREASE OF SKIN TEMPERATURE
IL259944B (en) 2016-01-18 2022-07-01 Ulthera Inc Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
BR112018072101B1 (en) 2016-08-16 2024-01-02 Ulthera, Inc SYSTEMS AND METHODS FOR COSMETIC SKIN TREATMENT WITH ULTRASOUND
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
CA3089137A1 (en) 2018-02-07 2019-08-15 Cynosure, Inc. Methods and apparatus for controlled rf treatments and rf generator system
US10799292B2 (en) * 2018-05-04 2020-10-13 Bin Rao High power tunable optical parametric oscillator for selective photothermolysis laser surgeries
EP3721939B1 (en) 2019-04-11 2022-07-06 BTL Healthcare Technologies a.s. Device for aesthetic treatment of biological structures by radiofrequency and magnetic energy
USD1005484S1 (en) 2019-07-19 2023-11-21 Cynosure, Llc Handheld medical instrument and docking base
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
KR20230000081U (en) 2020-05-04 2023-01-10 비티엘 헬쓰케어 테크놀로지스 에이.에스. Device and method for unattended treatment of patients
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304170A (en) * 1993-03-12 1994-04-19 Green Howard A Method of laser-induced tissue necrosis in carotenoid-containing skin structures
US5403306A (en) * 1993-06-22 1995-04-04 Vanderbilt University Laser surgery method
US5505727A (en) * 1991-09-25 1996-04-09 Keller; Gregory S. Method of laser cosmetic surgery
US5595568A (en) 1995-02-01 1997-01-21 The General Hospital Corporation Permanent hair removal using optical pulses
US5655547A (en) * 1996-05-15 1997-08-12 Esc Medical Systems Ltd. Method for laser surgery
US5735844A (en) 1995-02-01 1998-04-07 The General Hospital Corporation Hair removal using optical pulses
US5817089A (en) * 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
US5824023A (en) 1995-10-12 1998-10-20 The General Hospital Corporation Radiation-delivery device

Family Cites Families (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3327712A (en) 1961-09-15 1967-06-27 Ira H Kaufman Photocoagulation type fiber optical surgical device
US3538919A (en) 1967-04-07 1970-11-10 Gregory System Inc Depilation by means of laser energy
US3527932A (en) 1967-11-16 1970-09-08 James J Thomas Transilluminating flashlight
US3622743A (en) 1969-04-28 1971-11-23 Hrand M Muncheryan Laser eraser and microwelder
US3693623A (en) 1970-12-25 1972-09-26 Gregory System Inc Photocoagulation means and method for depilation
US3818914A (en) 1972-04-17 1974-06-25 Spectroderm Inc Apparatus and method for treatment of skin disorders
US3834391A (en) 1973-01-19 1974-09-10 Block Carol Ltd Method and apparatus for photoepilation
US3900034A (en) 1974-04-10 1975-08-19 Us Energy Photochemical stimulation of nerves
GB1485908A (en) 1974-05-21 1977-09-14 Nath G Apparatus for applying light radiation
US4273109A (en) 1976-07-06 1981-06-16 Cavitron Corporation Fiber optic light delivery apparatus and medical instrument utilizing same
DE7906381U1 (en) 1979-03-08 1979-07-12 Richard Wolf Gmbh, 7134 Knittlingen LIGHTING FOR OPERATIONAL AND EXAMINATION AREAS
GB2071500B (en) 1980-02-27 1984-03-21 Nath G Coagulator
US4316467A (en) 1980-06-23 1982-02-23 Lorenzo P. Maun Control for laser hemangioma treatment system
US4388924A (en) 1981-05-21 1983-06-21 Weissman Howard R Method for laser depilation
US4461294A (en) 1982-01-20 1984-07-24 Baron Neville A Apparatus and process for recurving the cornea of an eye
GB2123287B (en) 1982-07-09 1986-03-05 Anna Gunilla Sutton Depilaton device
JPS60123818A (en) 1983-12-08 1985-07-02 Olympus Optical Co Ltd Optical transmitter
US4608978A (en) 1983-09-26 1986-09-02 Carol Block Limited Method and apparatus for photoepiltion
US5140984A (en) 1983-10-06 1992-08-25 Proclosure, Inc. Laser healing method and apparatus
US5108388B1 (en) 1983-12-15 2000-09-19 Visx Inc Laser surgery method
JPS60148567A (en) 1984-01-13 1985-08-05 株式会社東芝 Laser treatment apparatus
IL75998A0 (en) 1984-08-07 1985-12-31 Medical Laser Research & Dev C Laser system for providing target tissue specific energy deposition
EP0215878B1 (en) 1985-03-29 1989-11-08 Eugène Jim POLITZER Method and apparatus for shaving the beard
US5196004A (en) * 1985-07-31 1993-03-23 C. R. Bard, Inc. Infrared laser catheter system
US4917084A (en) * 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
US5137530A (en) 1985-09-27 1992-08-11 Sand Bruce J Collagen treatment apparatus
US4695697A (en) 1985-12-13 1987-09-22 Gv Medical, Inc. Fiber tip monitoring and protection assembly
GB2184021A (en) 1985-12-13 1987-06-17 Micra Ltd Laser treatment apparatus for port wine stains
FR2591902B1 (en) 1985-12-23 1989-06-30 Collin Yvon EXTERNAL LASER THERAPY APPARATUS HAVING ONE OR MORE LASER DIODES IN SUCTION CUPS
FR2597744A1 (en) 1986-04-29 1987-10-30 Boussignac Georges CARDIO-VASCULAR CATHETER FOR LASER SHOOTING
US4926227A (en) 1986-08-01 1990-05-15 Nanometrics Inc. Sensor devices with internal packaged coolers
US4860744A (en) 1987-11-02 1989-08-29 Raj K. Anand Thermoelectrically controlled heat medical catheter
US4860172A (en) 1988-01-19 1989-08-22 Biotronics Associates, Inc. Lamp-based laser simulator
US5242437A (en) 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
DE3837248A1 (en) 1988-10-28 1990-05-03 Teichmann Heinrich Otto Dr Phy Device for treating skin lesions
US4945239A (en) * 1989-03-29 1990-07-31 Center For Innovative Technology Early detection of breast cancer using transillumination
US5263951A (en) 1989-04-21 1993-11-23 Kerus Medical Systems Correction of the optical focusing system of the eye using laser thermal keratoplasty
US5486172A (en) 1989-05-30 1996-01-23 Chess; Cyrus Apparatus for treating cutaneous vascular lesions
US5057104A (en) 1989-05-30 1991-10-15 Cyrus Chess Method and apparatus for treating cutaneous vascular lesions
US5182557A (en) 1989-09-20 1993-01-26 Semborg Recrob, Corp. Motorized joystick
DE3936367A1 (en) 1989-11-02 1991-05-08 Simon Pal SHAVER
SE465953B (en) 1990-04-09 1991-11-25 Morgan Gustafsson DEVICE FOR TREATMENT OF UNDESECTED EXTERNAL ACCOMMODATIONS
US5059192A (en) 1990-04-24 1991-10-22 Nardo Zaias Method of hair depilation
US5071417A (en) 1990-06-15 1991-12-10 Rare Earth Medical Lasers, Inc. Laser fusion of biological materials
US5065515A (en) 1991-01-24 1991-11-19 Warner-Lambert Company Thermally assisted shaving system
US5300097A (en) 1991-02-13 1994-04-05 Lerner Ethan A Fiber optic psoriasis treatment device
US5207671A (en) 1991-04-02 1993-05-04 Franken Peter A Laser debridement of wounds
RU2122848C1 (en) 1991-06-24 1998-12-10 Учебно-научно-производственный лазерный центр Санкт-Петербургского института точной механики и оптики Reflexotherapy device
US5178617A (en) 1991-07-09 1993-01-12 Laserscope System for controlled distribution of laser dosage
US5474549A (en) 1991-07-09 1995-12-12 Laserscope Method and system for scanning a laser beam for controlled distribution of laser dosage
US5225926A (en) 1991-09-04 1993-07-06 International Business Machines Corporation Durable optical elements fabricated from free standing polycrystalline diamond and non-hydrogenated amorphous diamond like carbon (dlc) thin films
US5226907A (en) 1991-10-29 1993-07-13 Tankovich Nikolai I Hair removal device and method
US5425728A (en) 1991-10-29 1995-06-20 Tankovich; Nicolai I. Hair removal device and method
US5344418A (en) 1991-12-12 1994-09-06 Shahriar Ghaffari Optical system for treatment of vascular lesions
US5275596A (en) 1991-12-23 1994-01-04 Laser Centers Of America Laser energy delivery tip element with throughflow of vaporized materials
US5405368A (en) 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
CA2093055C (en) 1992-04-09 2002-02-19 Shimon Eckhouse Method and apparatus for therapeutic electromagnetic treatment
US5334191A (en) 1992-05-21 1994-08-02 Dix Phillip Poppas Laser tissue welding control system
US5292320A (en) 1992-07-06 1994-03-08 Ceramoptec, Inc. Radial medical laser delivery device
DE69311478T2 (en) 1992-09-07 1998-01-02 Philips Electronics Nv Method for producing a block-shaped carrier body for a semiconductor component
US5720772A (en) * 1992-10-20 1998-02-24 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US6280438B1 (en) 1992-10-20 2001-08-28 Esc Medical Systems Ltd. Method and apparatus for electromagnetic treatment of the skin, including hair depilation
US5683380A (en) 1995-03-29 1997-11-04 Esc Medical Systems Ltd. Method and apparatus for depilation using pulsed electromagnetic radiation
US5620478A (en) 1992-10-20 1997-04-15 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US5626631A (en) 1992-10-20 1997-05-06 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US6315772B1 (en) 1993-09-24 2001-11-13 Transmedica International, Inc. Laser assisted pharmaceutical delivery and fluid removal
US5334193A (en) 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5707403A (en) * 1993-02-24 1998-01-13 Star Medical Technologies, Inc. Method for the laser treatment of subsurface blood vessels
US5350376A (en) 1993-04-16 1994-09-27 Ceramoptec, Inc. Optical controller device
US5415654A (en) 1993-10-05 1995-05-16 S.L.T. Japan Co., Ltd. Laser balloon catheter apparatus
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5413587A (en) 1993-11-22 1995-05-09 Hochstein; Peter A. Infrared heating apparatus and methods
AT400305B (en) 1994-03-07 1995-12-27 Divida Ges M B H Methoden Und Instrument for the treatment of skin zones
US5616140A (en) 1994-03-21 1997-04-01 Prescott; Marvin Method and apparatus for therapeutic laser treatment
US5505726A (en) 1994-03-21 1996-04-09 Dusa Pharmaceuticals, Inc. Article of manufacture for the photodynamic therapy of dermal lesion
RU2089126C1 (en) 1994-04-11 1997-09-10 Учебно-научно-производственный "Лазерный центр" Института точной механики и оптики Method of treatment of tooth hard tissues by laser radiation and device for its realization
US5519534A (en) 1994-05-25 1996-05-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane
US5586132A (en) * 1994-07-27 1996-12-17 Laser Industries Ltd. Method and apparatus for generating bright light sources
US5698866A (en) 1994-09-19 1997-12-16 Pdt Systems, Inc. Uniform illuminator for phototherapy
US5522813A (en) * 1994-09-23 1996-06-04 Coherent, Inc. Method of treating veins
US5531739A (en) * 1994-09-23 1996-07-02 Coherent, Inc. Method of treating veins
US5662643A (en) 1994-09-28 1997-09-02 Abiomed R & D, Inc. Laser welding system
US5735884A (en) 1994-10-04 1998-04-07 Medtronic, Inc. Filtered feedthrough assembly for implantable medical device
RU2089127C1 (en) 1994-11-02 1997-09-10 Григорий Борисович Альтшулер Method of treatment of tooth hard tissues by laser radiation and device for its realization
GB9514872D0 (en) * 1994-12-14 1995-09-20 Brine Lee Optical fibre laser delivery probe and use thereof
US5643334A (en) 1995-02-07 1997-07-01 Esc Medical Systems Ltd. Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment
RU2096051C1 (en) 1995-02-24 1997-11-20 Григорий Борисович Альтшулер Apparatus for laser treatment of biological tissues (alternative embodiments)
US5885273A (en) 1995-03-29 1999-03-23 Esc Medical Systems, Ltd. Method for depilation using pulsed electromagnetic radiation
RU2082337C1 (en) 1995-04-10 1997-06-27 Григорий Борисович Альтшулер Tip piece of laser system for treating biological tissue
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5879376A (en) 1995-07-12 1999-03-09 Luxar Corporation Method and apparatus for dermatology treatment
US5658323A (en) * 1995-07-12 1997-08-19 Miller; Iain D. Method and apparatus for dermatology treatment
US5849029A (en) 1995-12-26 1998-12-15 Esc Medical Systems, Ltd. Method for controlling the thermal profile of the skin
US5964749A (en) 1995-09-15 1999-10-12 Esc Medical Systems Ltd. Method and apparatus for skin rejuvenation and wrinkle smoothing
US5836999A (en) 1995-09-28 1998-11-17 Esc Medical Systems Ltd. Method and apparatus for treating psoriasis using pulsed electromagnetic radiation
US5776175A (en) 1995-09-29 1998-07-07 Esc Medical Systems Ltd. Method and apparatus for treatment of cancer using pulsed electromagnetic radiation
IT1286551B1 (en) * 1996-02-13 1998-07-15 El En S R L DEVICE AND METHOD FOR THE ELIMINATION OF ADIPOSE LAYERS THROUGH LASER ENERGY
US5630811A (en) 1996-03-25 1997-05-20 Miller; Iain D. Method and apparatus for hair removal
US5662644A (en) 1996-05-14 1997-09-02 Mdlt, Inc. Dermatological laser apparatus and method
US5743901A (en) 1996-05-15 1998-04-28 Star Medical Technologies, Inc. High fluence diode laser device and method for the fabrication and use thereof
US5944748A (en) 1996-07-25 1999-08-31 Light Medicine, Inc. Photodynamic therapy apparatus and methods
US5820626A (en) 1996-07-30 1998-10-13 Laser Aesthetics, Inc. Cooling laser handpiece with refillable coolant reservoir
AU3825097A (en) * 1996-08-06 1998-02-25 Edward W. Knowlton Method for tightening skin
US5913883A (en) * 1996-08-06 1999-06-22 Alexander; Dane Therapeutic facial mask
US6096029A (en) 1997-02-24 2000-08-01 Laser Skin Toner, Inc. Laser method for subsurface cutaneous treatment
US5759200A (en) 1996-09-04 1998-06-02 Azar; Zion Method of selective photothermolysis
JP3036232U (en) 1996-09-26 1997-04-15 ヤーマン株式会社 Optical hair removal device
US5782249A (en) 1996-09-30 1998-07-21 Weber; Paul J. Laser manicure process
US6015404A (en) 1996-12-02 2000-01-18 Palomar Medical Technologies, Inc. Laser dermatology with feedback control
US6517532B1 (en) * 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US6162211A (en) 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
US5830208A (en) 1997-01-31 1998-11-03 Laserlite, Llc Peltier cooled apparatus and methods for dermatological treatment
US5810801A (en) 1997-02-05 1998-09-22 Candela Corporation Method and apparatus for treating wrinkles in skin using radiation
US5891063A (en) * 1997-04-03 1999-04-06 Vigil; Arlene Skin rejuvinating system
JP4056091B2 (en) * 1997-05-15 2008-03-05 パロマー・メディカル・テクノロジーズ・インコーポレーテッド Dermatological treatment method and apparatus
US5968034A (en) 1997-06-24 1999-10-19 Laser Aesthetics, Inc. Pulsed filament lamp for dermatological treatment
US5885274A (en) 1997-06-24 1999-03-23 New Star Lasers, Inc. Filament lamp for dermatological treatment
US6104959A (en) 1997-07-31 2000-08-15 Microwave Medical Corp. Method and apparatus for treating subcutaneous histological features
US6273885B1 (en) 1997-08-16 2001-08-14 Cooltouch Corporation Handheld photoepilation device and method
US6074382A (en) 1997-08-29 2000-06-13 Asah Medico A/S Apparatus for tissue treatment
US5968033A (en) 1997-11-03 1999-10-19 Fuller Research Corporation Optical delivery system and method for subsurface tissue irradiation
AU1934699A (en) * 1998-01-07 1999-07-26 Kim Robin Segal Diode laser irradiation and electrotherapy system for biological tissue stimulation
US6149644A (en) * 1998-02-17 2000-11-21 Altralight, Inc. Method and apparatus for epidermal treatment with computer controlled moving focused infrared light
US6080146A (en) * 1998-02-24 2000-06-27 Altshuler; Gregory Method and apparatus for hair removal
WO1999046005A1 (en) * 1998-03-12 1999-09-16 Palomar Medical Technologies, Inc. System for electromagnetic radiation of the skin
AU3363999A (en) * 1998-03-27 1999-10-18 General Hospital Corporation, The Method and apparatus for the selective targeting of lipid-rich tissues
US6059820A (en) 1998-10-16 2000-05-09 Paradigm Medical Corporation Tissue cooling rod for laser surgery
US6096209A (en) 1998-11-25 2000-08-01 Aws Industries, L.L.C. Three media silver recovery apparatus
US6235016B1 (en) 1999-03-16 2001-05-22 Bob W. Stewart Method of reducing sebum production by application of pulsed light
US6214035B1 (en) * 1999-03-23 2001-04-10 Jackson Streeter Method for improving cardiac microcirculation
DE19914108A1 (en) 1999-03-23 2000-10-05 Plasmaphotonics Gmbh Irradiation arrangement, in particular for optical thermolysis
US6354370B1 (en) * 1999-12-16 2002-03-12 The United States Of America As Represented By The Secretary Of The Air Force Liquid spray phase-change cooling of laser devices
GB2360946B (en) 2000-04-08 2002-06-12 Lynton Lasers Ltd Dermatological treatment apparatus

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505727A (en) * 1991-09-25 1996-04-09 Keller; Gregory S. Method of laser cosmetic surgery
US5817089A (en) * 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
US5304170A (en) * 1993-03-12 1994-04-19 Green Howard A Method of laser-induced tissue necrosis in carotenoid-containing skin structures
US5403306A (en) * 1993-06-22 1995-04-04 Vanderbilt University Laser surgery method
US5595568A (en) 1995-02-01 1997-01-21 The General Hospital Corporation Permanent hair removal using optical pulses
US5735844A (en) 1995-02-01 1998-04-07 The General Hospital Corporation Hair removal using optical pulses
US5824023A (en) 1995-10-12 1998-10-20 The General Hospital Corporation Radiation-delivery device
US5655547A (en) * 1996-05-15 1997-08-12 Esc Medical Systems Ltd. Method for laser surgery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1066086A4

Cited By (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544255B2 (en) 1997-04-04 2003-04-08 Keralase Ltd. Method of hair removal by transcutaneous application of laser light
US6743222B2 (en) 1999-12-10 2004-06-01 Candela Corporation Method of treating disorders associated with sebaceous follicles
EP1294444A4 (en) * 2000-04-03 2005-08-10 Ceramoptec Gmbh Therapeutic laser system operating between 1000 and 1300 nm and its use
EP1294444A2 (en) * 2000-04-03 2003-03-26 CeramOptec GmbH Therapeutic laser system operating between 1000 and 1300 nm and its use
US7384797B1 (en) 2000-10-12 2008-06-10 University Of Utah Research Foundation Resonant optical cavities for high-sensitivity high-throughput biological sensors and methods
US7470270B2 (en) 2001-06-27 2008-12-30 Radiancy Inc. Acne treatment
US6723090B2 (en) 2001-07-02 2004-04-20 Palomar Medical Technologies, Inc. Fiber laser device for medical/cosmetic procedures
US11590020B2 (en) 2002-03-15 2023-02-28 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
CN110522505A (en) * 2002-03-15 2019-12-03 总医院公司 The method and apparatus that selective destruction is carried out to adipose tissue by controlled cooling
EP2260801B1 (en) * 2002-03-15 2017-01-11 The General Hospital Corporation Method for selective disruption of fatty tissue by controlled cooling
US9308120B2 (en) 2002-03-15 2016-04-12 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
EP3173042A1 (en) * 2002-03-15 2017-05-31 The General Hospital Corporation Method and devices for selective disruption of fatty tissue by controlled cooling
EP2260801A2 (en) 2002-03-15 2010-12-15 The General Hospital Corporation Method for selective disruption of fatty tissue by controlled cooling
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
AU2003238302B2 (en) * 2002-06-19 2008-12-11 Palomar Medical Technologies, Inc Method and apparatus for photothermal treatment of tissue at depth
US10556123B2 (en) 2002-06-19 2020-02-11 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US10500413B2 (en) 2002-06-19 2019-12-10 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
WO2004000150A1 (en) * 2002-06-19 2003-12-31 Palomar Medical Technologies, Inc. Method and apparatus for photothermal treatment of tissue at depth
JP2006500972A (en) * 2002-06-19 2006-01-12 パロマー・メディカル・テクノロジーズ・インコーポレイテッド Method and apparatus for treating tissue at a depth by radiant heat
WO2004041104A1 (en) * 2002-11-04 2004-05-21 Universita' Degli Studi Di Padova Laser apparatus for treating hard tissues and method for using the apparatus
WO2004073537A3 (en) * 2003-02-19 2004-12-02 Palomar Medical Tech Inc Method and apparatus for treating pseudofolliculitis barbae
WO2004073537A2 (en) * 2003-02-19 2004-09-02 Palomar Medical Technologies, Inc. Method and apparatus for treating pseudofolliculitis barbae
US8790381B2 (en) 2003-02-28 2014-07-29 Photometics, Inc. Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy
US20110040295A1 (en) * 2003-02-28 2011-02-17 Photometics, Inc. Cancer treatment using selective photo-apoptosis
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
WO2007118246A1 (en) * 2006-04-07 2007-10-18 The General Hospital Corporation Method, system and apparatus for dermatological treatment and fractusal skin resurfacing
US9486285B2 (en) 2006-06-14 2016-11-08 Candela Corporation Treatment of skin by spatial modulation of thermal heating
WO2008008971A1 (en) * 2006-07-13 2008-01-17 Candela Corporation Compact, handheld device for home-based acne treatment
US10966785B2 (en) 2006-08-02 2021-04-06 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US11712299B2 (en) 2006-08-02 2023-08-01 Cynosure, LLC. Picosecond laser apparatus and methods for its operation and use
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US10849687B2 (en) 2006-08-02 2020-12-01 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US11395760B2 (en) 2006-09-26 2022-07-26 Zeltiq Aesthetics, Inc. Tissue treatment methods
US11219549B2 (en) 2006-09-26 2022-01-11 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US10292859B2 (en) 2006-09-26 2019-05-21 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US11179269B2 (en) 2006-09-26 2021-11-23 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US10869687B2 (en) 2006-12-22 2020-12-22 Spectranetics Llc Tissue separating systems and methods
US9801650B2 (en) 2006-12-22 2017-10-31 The Spectranetics Corporation Tissue separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US9289226B2 (en) 2006-12-22 2016-03-22 The Spectranetics Corporation Retractable separating systems and methods
US10537354B2 (en) 2006-12-22 2020-01-21 The Spectranetics Corporation Retractable separating systems and methods
US9808275B2 (en) 2006-12-22 2017-11-07 The Spectranetics Corporation Retractable separating systems and methods
EP2578176A1 (en) * 2007-03-02 2013-04-10 Candela Corporation Variable depth skin heating with lasers
US20080215040A1 (en) * 2007-03-02 2008-09-04 Paithankar Dilip Y Variable depth skin heating with lasers
US10383787B2 (en) 2007-05-18 2019-08-20 Zeltiq Aesthetics, Inc. Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue
US11291606B2 (en) 2007-05-18 2022-04-05 Zeltiq Aesthetics, Inc. Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue
US9655770B2 (en) 2007-07-13 2017-05-23 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US11583438B1 (en) 2007-08-21 2023-02-21 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US9408745B2 (en) 2007-08-21 2016-08-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US10675178B2 (en) 2007-08-21 2020-06-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US9518288B2 (en) 2008-04-11 2016-12-13 University Of Utah Research Foundation Methods and compositions related to quantitative, array based methylation analysis
US9737434B2 (en) 2008-12-17 2017-08-22 Zeltiq Aestehtics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
US11224536B2 (en) 2009-04-30 2022-01-18 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US9861520B2 (en) 2009-04-30 2018-01-09 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US11452634B2 (en) 2009-04-30 2022-09-27 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
US9314368B2 (en) 2010-01-25 2016-04-19 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods
US10092346B2 (en) 2010-07-20 2018-10-09 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
US10722395B2 (en) 2011-01-25 2020-07-28 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US11664637B2 (en) 2012-04-18 2023-05-30 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11095087B2 (en) 2012-04-18 2021-08-17 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US10581217B2 (en) 2012-04-18 2020-03-03 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US10305244B2 (en) 2012-04-18 2019-05-28 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US11596435B2 (en) 2012-09-14 2023-03-07 Specrtranetics Llc Tissue slitting methods and systems
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US9763692B2 (en) 2012-09-14 2017-09-19 The Spectranetics Corporation Tissue slitting methods and systems
US9724122B2 (en) 2012-09-14 2017-08-08 The Spectranetics Corporation Expandable lead jacket
US9949753B2 (en) 2012-09-14 2018-04-24 The Spectranetics Corporation Tissue slitting methods and systems
US10531891B2 (en) 2012-09-14 2020-01-14 The Spectranetics Corporation Tissue slitting methods and systems
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
US10265520B2 (en) 2013-03-13 2019-04-23 The Spetranetics Corporation Alarm for lead insulation abnormality
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US10799293B2 (en) 2013-03-13 2020-10-13 The Spectranetics Corporation Laser ablation catheter
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US9925371B2 (en) 2013-03-13 2018-03-27 The Spectranetics Corporation Alarm for lead insulation abnormality
US9937005B2 (en) 2013-03-13 2018-04-10 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US10485613B2 (en) 2013-03-13 2019-11-26 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US11925380B2 (en) 2013-03-14 2024-03-12 Spectranetics Llc Distal end supported tissue slitting apparatus
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US11446086B2 (en) 2013-03-15 2022-09-20 Cynosure, Llc Picosecond optical radiation systems and methods of use
US10314615B2 (en) 2013-03-15 2019-06-11 The Spectranetics Corporation Medical device for removing an implanted object
US11160579B2 (en) 2013-03-15 2021-11-02 Spectranetics Llc Multiple configuration surgical cutting device
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
US9956399B2 (en) 2013-03-15 2018-05-01 The Spectranetics Corporation Medical device for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10524817B2 (en) 2013-03-15 2020-01-07 The Spectranetics Corporation Surgical instrument including an inwardly deflecting cutting tip for removing an implanted object
US11925334B2 (en) 2013-03-15 2024-03-12 Spectranetics Llc Surgical instrument for removing an implanted object
US10219819B2 (en) 2013-03-15 2019-03-05 The Spectranetics Corporation Retractable blade for lead removal device
US10765478B2 (en) 2013-03-15 2020-09-08 Cynosurce, Llc Picosecond optical radiation systems and methods of use
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US9918737B2 (en) 2013-03-15 2018-03-20 The Spectranetics Corporation Medical device for removing an implanted object
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US10052129B2 (en) 2013-03-15 2018-08-21 The Spectranetics Corporation Medical device for removing an implanted object
US10849603B2 (en) 2013-03-15 2020-12-01 Spectranetics Llc Surgical instrument for removing an implanted object
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US10201380B2 (en) 2014-01-31 2019-02-12 Zeltiq Aesthetics, Inc. Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments
US10912599B2 (en) 2014-01-31 2021-02-09 Zeltiq Aesthetics, Inc. Compositions, treatment systems and methods for improved cooling of lipid-rich tissue
US10806500B2 (en) 2014-01-31 2020-10-20 Zeltiq Aesthetics, Inc. Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments
US10575890B2 (en) 2014-01-31 2020-03-03 Zeltiq Aesthetics, Inc. Treatment systems and methods for affecting glands and other targeted structures
US9861421B2 (en) 2014-01-31 2018-01-09 Zeltiq Aesthetics, Inc. Compositions, treatment systems and methods for improved cooling of lipid-rich tissue
US11819257B2 (en) 2014-01-31 2023-11-21 Zeltiq Aesthetics, Inc. Compositions, treatment systems and methods for improved cooling of lipid-rich tissue
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
USD806245S1 (en) 2015-02-20 2017-12-26 The Spectranetics Corporation Medical device handle
USD854682S1 (en) 2015-02-20 2019-07-23 The Spectranetics Corporation Medical device handle
USD819204S1 (en) 2015-02-20 2018-05-29 The Spectranetics Corporation Medical device handle
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
US11154418B2 (en) 2015-10-19 2021-10-26 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
US10524956B2 (en) 2016-01-07 2020-01-07 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
US11400308B2 (en) 2017-11-21 2022-08-02 Cutera, Inc. Dermatological picosecond laser treatment systems and methods using optical parametric oscillator
US11791603B2 (en) 2018-02-26 2023-10-17 Cynosure, LLC. Q-switched cavity dumped sub-nanosecond laser
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11446175B2 (en) 2018-07-31 2022-09-20 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
US10864380B1 (en) 2020-02-29 2020-12-15 Cutera, Inc. Systems and methods for controlling therapeutic laser pulse duration
US11738206B2 (en) 2020-02-29 2023-08-29 Cutera, Inc. Systems and methods for controlling therapeutic laser pulse duration
US11253720B2 (en) 2020-02-29 2022-02-22 Cutera, Inc. Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing

Also Published As

Publication number Publication date
EP1066086A4 (en) 2007-08-15
US7060061B2 (en) 2006-06-13
EP2263749A3 (en) 2012-09-26
AU3363999A (en) 1999-10-18
US6605080B1 (en) 2003-08-12
CA2326120C (en) 2015-01-13
ES2640937T3 (en) 2017-11-07
EP1066086B1 (en) 2013-01-02
ES2403359T3 (en) 2013-05-17
EP2263749B1 (en) 2017-06-21
EP2263749A2 (en) 2010-12-22
CA2326120A1 (en) 1999-10-07
EP1066086A1 (en) 2001-01-10
US20040034341A1 (en) 2004-02-19
US20030199859A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
EP2263749B1 (en) Method for the selective targeting of sebaceous glands
US5707403A (en) Method for the laser treatment of subsurface blood vessels
US5853407A (en) Method and apparatus for hair removal
JP3245426B2 (en) Alexandrite laser system for treating dermatological specimens
Wheeland Laser-assisted hair removal
US7217265B2 (en) Treatment of cellulite with mid-infrared radiation
US6723090B2 (en) Fiber laser device for medical/cosmetic procedures
Patil Overview of lasers
US5984915A (en) Percutaneous laser treatment
EP0860123B1 (en) hair removal device
US6077294A (en) Method for non-invasive wrinkle removal and skin treatment
EP2010087B1 (en) Apparatus for producing thermal damage within the skin
US6808532B2 (en) Laser treatment for reducing wrinkles
US20120029394A1 (en) Ultrasound Assisted Laser Skin and Tissue Treatment
US20080269735A1 (en) Optical array for treating biological tissue
JPH09215695A (en) Epilation method and apparatus using pulse electromagnetic radiation
US6702838B1 (en) Method of treating hypotrophic scars enlarged pores
US20140017635A1 (en) Medical treatment apparatus with laser pulses in the femtosecond range
WO2000057229A1 (en) Direct diode laser with fiber delivery
Weir et al. Photo-assisted epilation—review and personal observations
Boechat et al. Lasers, Lights, and Related Technologies in Cosmetic Dermatology
Neev et al. Thermo-optical skin conditioning: a new method for thermally modifying skin conditions
Sadick et al. Long-pulsed Nd: YAG (1064 nm) lasers
Hartwig Lasers in dermatology
Jovanovic et al. Ablation of dermal and mucosal lesions with a new CO2 laser application system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2326120

Country of ref document: CA

Ref country code: CA

Ref document number: 2326120

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999915023

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999915023

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642